BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402-405. [PMID: 9537325 DOI: 10.1038/32918] [Cited by in Crossref: 1119] [Cited by in F6Publishing: 1216] [Article Influence: 44.8] [Reference Citation Analysis]
Number Citing Articles
1 Knipper K, Fuchs HF, Alakus H, Bruns CJ, Schmidt T. [Hereditary diffuse gastric cancer]. Chirurgie (Heidelb) 2023. [PMID: 36700973 DOI: 10.1007/s00104-023-01806-z] [Reference Citation Analysis]
2 Petrillo A, Federico P, Marte G, Liguori C, Seeber A, Ottaviano M, Tufo A, Daniele B. Non-hereditary early onset gastric cancer: An unmet medical need. Curr Opin Pharmacol 2023;68:102344. [PMID: 36608410 DOI: 10.1016/j.coph.2022.102344] [Reference Citation Analysis]
3 Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, Sousa S, Pinheiro H, Sousa L, Monteiro R, Maqueda JJ, Fernandes S, Carneiro F, Pinto N, Lemos C, Pinto C, Teixeira MR, Aretz S, Bajalica-Lagercrantz S, Balmaña J, Blatnik A, Benusiglio PR, Blanluet M, Bours V, Brems H, Brunet J, Calistri D, Capellá G, Carrera S, Colas C, Dahan K, de Putter R, Desseignés C, Domínguez-Garrido E, Egas C, Evans DG, Feret D, Fewings E, Fitzgerald RC, Coulet F, Garcia-Barcina M, Genuardi M, Golmard L, Hackmann K, Hanson H, Holinski-Feder E, Hüneburg R, Krajc M, Lagerstedt-Robinson K, Lázaro C, Ligtenberg MJL, Martínez-Bouzas C, Merino S, Michils G, Novaković S, Patiño-García A, Ranzani GN, Schröck E, Silva I, Silveira C, Soto JL, Spier I, Steinke-Lange V, Tedaldi G, Tejada MI, Woodward ER, Tischkowitz M, Hoogerbrugge N, Oliveira C. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. Lancet Oncol 2023;24:91-106. [PMID: 36436516 DOI: 10.1016/S1470-2045(22)00643-X] [Reference Citation Analysis]
4 Sokolova A, Johnstone KJ, McCart Reed AE, Simpson PT, Lakhani SR. Hereditary breast cancer: syndromes, tumour pathology and molecular testing. Histopathology 2023;82:70-82. [PMID: 36468211 DOI: 10.1111/his.14808] [Reference Citation Analysis]
5 Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O'Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lancet Oncol 2023;24:107-16. [PMID: 36509094 DOI: 10.1016/S1470-2045(22)00700-8] [Reference Citation Analysis]
6 Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Hereditary Diffuse Gastric Cancer: A 2022 Update. J Pers Med 2022;12. [PMID: 36556253 DOI: 10.3390/jpm12122032] [Reference Citation Analysis]
7 Raymond JH, Pouteaux M, Petit V, Aktary Z, Luciani F, Wehbe M, Gizzi P, Bourban C, Martianov I, Davidson I, Tomasetto C, Betzer F, Vergier B, Larue L, Delmas V. The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma.. [DOI: 10.1101/2022.12.02.518844] [Reference Citation Analysis]
8 Malpeli G, Barbi S, Innamorati G, Alloggio M, Filippini F, Decimo I, Castelli C, Perris R, Bencivenga M. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. J Pers Med 2022;12. [PMID: 36556227 DOI: 10.3390/jpm12122006] [Reference Citation Analysis]
9 Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022;126:1413-22. [PMID: 36063148 DOI: 10.1002/jso.27084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ter Steege EJ, Sijnesael T, Enserink L, Klarenbeek S, Haakma WE, Bakker ERM, Derksen PWB. LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice. Neoplasia 2023;35:100844. [PMID: 36371908 DOI: 10.1016/j.neo.2022.100844] [Reference Citation Analysis]
11 Stanich PP, Elgindi D, Stoffel E, Koeppe E, Bansal A, Stetson R, Collins DL, Clark DF, Karloski E, Dudley B, Brand RE, Hall MJ, Chertock Y, Sullivan BA, Muller C, Hinton A, Katona BW, Kupfer SS. Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis. Am J Gastroenterol 2022;117:1877-9. [PMID: 36087100 DOI: 10.14309/ajg.0000000000001996] [Reference Citation Analysis]
12 Bluebond R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm143.pub2] [Reference Citation Analysis]
13 Long JM, Ebrahimzadeh J, Stanich PP, Katona BW. Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions. Cancer Manag Res 2022;14:2953-69. [PMID: 36238953 DOI: 10.2147/CMAR.S277898] [Reference Citation Analysis]
14 Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, Zeng Q, Zeng L, Pan Y, Chen ZS, He Y. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther 2022;7:358. [PMID: 36209270 DOI: 10.1038/s41392-022-01190-w] [Reference Citation Analysis]
15 Coit DG, Strong VE. Fifty years of progress in gastric cancer. J Surg Oncol 2022;126:865-71. [PMID: 36087088 DOI: 10.1002/jso.27060] [Reference Citation Analysis]
16 Corso G, Magnoni F, Veronesi P. Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer. Ann Surg Oncol. [DOI: 10.1245/s10434-022-12542-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang X, Sun J, Shao K, Zhi H, Lin Y, Fu Y, Liu Z. Study on the interactions between cisplatin and cadherin.. [DOI: 10.1101/2022.09.11.507507] [Reference Citation Analysis]
18 Shah IH, Salo-Mullen EE, Amoroso KA, Kelsen D, Stadler ZK, Hamilton JG. Attitudes toward preimplantation genetic testing and quality of life among individuals with hereditary diffuse gastric cancer syndrome. Hered Cancer Clin Pract 2022;20:31. [PMID: 36056367 DOI: 10.1186/s13053-022-00239-9] [Reference Citation Analysis]
19 Celik B, Tuncer SB. Investigation of CDH1 germline mutations in Turkish patients with Kaposi’s sarcoma. Turkish Journal of Biochemistry 2022;0. [DOI: 10.1515/tjb-2022-0032] [Reference Citation Analysis]
20 Yamaguchi H, Nagamura Y, Miyazaki M. Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors. Cancers 2022;14:3750. [DOI: 10.3390/cancers14153750] [Reference Citation Analysis]
21 Corso G, Tagliaferri V, Massari G, Cioffi A, Rossi EMC, Veronesi P, Magnoni F. CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study. Fam Cancer 2022. [PMID: 35882702 DOI: 10.1007/s10689-022-00309-w] [Reference Citation Analysis]
22 Ni Y, Low JT, Silke J, O'Reilly LA. Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers. Front Immunol 2022;13:835997. [PMID: 35844493 DOI: 10.3389/fimmu.2022.835997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Yoshimura A, Imoto I, Iwata H. Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. Int J Mol Sci 2022;23:7481. [PMID: 35806485 DOI: 10.3390/ijms23137481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Gu C, Xie L, Li B, Zhang L, Li F, Wang W, Su J, Xu Z. Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer. Clin Med Insights Oncol 2022;16:11795549221104440. [PMID: 35774594 DOI: 10.1177/11795549221104440] [Reference Citation Analysis]
26 Choi YJ, Kim B, Kim Y, Shin S, Lee K. Applying Functional Assay Evidence to Interpret Sequence Variants Identified in Hereditary Cancer Genes. Lab Med Online 2022;12:145-158. [DOI: 10.47429/lmo.2022.12.3.145] [Reference Citation Analysis]
27 Huang Z, Zhang Z, Zhou C, Liu L, Huang C. Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm 2022;3. [DOI: 10.1002/mco2.144] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
28 Calaf GM, Crispin LA, Muñoz JP, Aguayo F, Bleak TC. Muscarinic Receptors Associated with Cancer. Cancers 2022;14:2322. [DOI: 10.3390/cancers14092322] [Reference Citation Analysis]
29 Ruf B, Roggia C, Schroeder C, Mattern S, Fend F, Klag T, Götz M. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. J Gastrointest Canc. [DOI: 10.1007/s12029-022-00831-1] [Reference Citation Analysis]
30 Shah D, Bentrem D. Environmental and genetic risk factors for gastric cancer. J Surg Oncol 2022;125:1096-103. [PMID: 35481919 DOI: 10.1002/jso.26869] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Treese C, Siegmund B, Daum S. Hereditary Diffuse Gastric Cancer—Update Based on the Current Consort Recommendations. Current Oncology 2022;29:2454-60. [DOI: 10.3390/curroncol29040199] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Santos Marques H, de Brito BB, França da Silva FA, Souza CL, Oliveira MV, de Melo FF. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. World J Clin Oncol 2022; 13(3): 186-199 [DOI: 10.5306/wjco.v13.i3.186] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Fossmark R, Johannessen R, Qvigstad G, Mjønes P. Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin? Medicina 2022;58:470. [DOI: 10.3390/medicina58040470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Bougen-Zhukov N, Decourtye-Espiard L, Mitchell W, Redpath K, Perkinson J, Godwin T, Black MA, Guilford P. E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib. Cancers (Basel) 2022;14:1609. [PMID: 35406381 DOI: 10.3390/cancers14071609] [Reference Citation Analysis]
35 Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
36 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Di J, Chai Y, Yang X, Dong H, Jiang B, Ji F. ELP6 and PLIN5 Mutations Were Probably Prognostic Biomarkers for Patients With Gastric Cancer. Front Med (Lausanne) 2022;9:803617. [PMID: 35223903 DOI: 10.3389/fmed.2022.803617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sommer AK, te Paske IB, Garcia-pelaez J, Laner A, Holinski-feder E, Steinke-lange V, Peters S, Valle L, Spier I, Huntsman D, Capella G, Evans G, Rump A, Schröck E, Hoischen A, Geverink N, Tischkowitz M, Matalonga L, Laurie S, Gilissen C, Steyaert W, Demidov G, Oliveira C, de Voer RM, Hoogerbrugge N, Aretz S. Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes– a collaborative multicentre endeavour within the project Solve-RD. European Journal of Medical Genetics 2022. [DOI: 10.1016/j.ejmg.2022.104475] [Reference Citation Analysis]
39 Uetake Y, Kojima S, Ogawa F, Kojima N, Mori M, Yajima K, Ho Kim D. A Case of Clinically Suspected Hereditary Diffuse Gastric Cancer with a History of Lobular Breast Cancer and Multiple Diffuse Gastric Cancer. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2022;55:73-81. [DOI: 10.5833/jjgs.2020.0180] [Reference Citation Analysis]
40 Forrester JD, Foster D, Ford JM, Longacre TA, Ladabaum U, Fry S, Norton JA. Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes. Cancers (Basel) 2022;14:728. [PMID: 35158993 DOI: 10.3390/cancers14030728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Takeuchi C, Sato J, Yamashita S, Sasaki A, Akahane T, Aoki R, Yamamichi M, Liu YY, Ito M, Furuta T, Nakajima S, Sakaguchi Y, Takahashi Y, Tsuji Y, Niimi K, Tomida S, Fujishiro M, Yamamichi N, Ushijima T. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. J Gastroenterol 2022. [PMID: 35034200 DOI: 10.1007/s00535-021-01848-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shamir ER, Hwang H, Chen Y. Invasive Lobular Carcinoma. A Comprehensive Guide to Core Needle Biopsies of the Breast 2022. [DOI: 10.1007/978-3-031-05532-4_15] [Reference Citation Analysis]
43 Pehlivanoglu B, Unlu SM. Biomarkers in Gastrointestinal System Carcinomas. Biomarkers in Carcinoma of Unknown Primary 2022. [DOI: 10.1007/978-3-030-84432-5_7] [Reference Citation Analysis]
44 Corso G, Magnoni F, Trovato C, Girardi A, Seruca R, Figueiredo J, Roviello F. Hereditary Gastric Cancer: A New Syndrome. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_5] [Reference Citation Analysis]
45 Vaiphei K. Helicobacter pylori Negative Gastric Cancer. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_16] [Reference Citation Analysis]
46 Li J, Lin F. Upper Gastrointestinal Tract. Handbook of Practical Immunohistochemistry 2022. [DOI: 10.1007/978-3-030-83328-2_28] [Reference Citation Analysis]
47 Vaiphei K. Morphological Aspect of Gastric Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_15] [Reference Citation Analysis]
48 Bernstein-molho R, Kaufman B, Wyld L. Genetic Syndromes and RT for Breast Cancer. Breast Cancer Radiation Therapy 2022. [DOI: 10.1007/978-3-030-91170-6_48] [Reference Citation Analysis]
49 Brew T, Bougen-Zhukov N, Mitchell W, Decourtye L, Schulpen E, Nouri Y, Godwin T, Guilford P. Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking. Cancers (Basel) 2021;14:102. [PMID: 35008266 DOI: 10.3390/cancers14010102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM, Vicini E, Bonanni B, Veronesi P, Galimberti V, Bagnardi V. CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. J Med Genet 2021:jmedgenet-2021-108226. [PMID: 34952833 DOI: 10.1136/jmedgenet-2021-108226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Adib E, El Zarif T, Nassar AH, Akl EW, Abou Alaiwi S, Mouhieddine TH, Esplin ED, Hatchell K, Nielsen SM, Rana HQ, Choueiri TK, Kwiatkowski DJ, Sonpavde G. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 2021. [PMID: 34949788 DOI: 10.1038/s41416-021-01673-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Santarosa M, Maestro R. The Autophagic Route of E-Cadherin and Cell Adhesion Molecules in Cancer Progression. Cancers (Basel) 2021;13:6328. [PMID: 34944948 DOI: 10.3390/cancers13246328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
54 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Gamble LA, Davis JL. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer. Gastrointest Endosc Clin N Am 2022;32:163-75. [PMID: 34798984 DOI: 10.1016/j.giec.2021.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Miyamoto S, Nagano Y, Miyazaki M, Nagamura Y, Sasaki K, Kawamura T, Yanagihara K, Imai T, Ohki R, Yashiro M, Tanaka M, Sakai R, Yamaguchi H. Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma. Cancer Lett 2021:S0304-3835(21)00575-9. [PMID: 34775002 DOI: 10.1016/j.canlet.2021.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Taja-Chayeb L, Vidal-Millán S, Trejo-Becerril C, Pérez-Cárdenas E, Chávez-Blanco A, Domínguez-Gómez G, González-Fierro A, Romo-Pérez A, Dueñas-González A. Hereditary Diffuse Gastric Cancer (HDGC). An overview. Clin Res Hepatol Gastroenterol 2021;:101820. [PMID: 34656755 DOI: 10.1016/j.clinre.2021.101820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Gamble LA, Rossi A, Fasaye GA, Kesserwan C, Hernandez JM, Blakely AM, Davis JL. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surg 2021. [PMID: 34643667 DOI: 10.1001/jamasurg.2021.5118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Okamoto K, Kodama M, Mizukami K, Okimoto T, Abe H, Ogawa R, Fukuda K, Matsunari O, Hirashita Y, Wada Y, Fukuda M, Murakami K. Immunohistochemical differences in gastric mucosal damage between nodular and non-nodular gastritis caused by Helicobacter pylori infection. J Clin Biochem Nutr 2021;69:216-21. [PMID: 34616112 DOI: 10.3164/jcbn.20-179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Zhang YJ, Yang Y, Wei Q, Xu T, Zhang XT, Gao J, Tan SY, Liu BR, Zhang JD, Chen XB, Wang ZJ, Qiu M, Wang X, Shen L, Wang XC. A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients. Gastroenterol Rep (Oxf) 2021;9:339-49. [PMID: 34567566 DOI: 10.1093/gastro/goab020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Pan Z, Fu Z, Luo C, Bao Y, Wang M, Cao W, Xu X. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer. J Cancer Res Clin Oncol 2021. [PMID: 34537906 DOI: 10.1007/s00432-021-03775-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Karsten N, Kolben T, Mahner S, Beyer S, Meister S, Kuhn C, Schmoeckel E, Wuerstlein R, Harbeck N, Ditsch N, Jeschke U, Friese K, Kolben TM. The role of E-Cadherin expression in primary site of breast cancer. Arch Gynecol Obstet 2021. [PMID: 34510244 DOI: 10.1007/s00404-021-06198-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Figueiredo J, Ferreira RM, Xu H, Gonçalves M, Barros-Carvalho A, Cravo J, Maia AF, Carneiro P, Figueiredo C, Smith ML, Stamenović D, Morais-de-Sá E, Seruca R. Integrin β1 orchestrates the abnormal cell-matrix attachment and invasive behaviour of E-cadherin dysfunctional cells. Gastric Cancer 2021. [PMID: 34486077 DOI: 10.1007/s10120-021-01239-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Barbosa-Matos R, Leal Silva R, Garrido L, Aguiar AC, Garcia-Pelaez J, André A, Seixas S, Sousa SP, Ferro L, Vilarinho L, Gullo I, Devezas V, Oliveira R, Fernandes S, Costa SC, Magalhães A, Baptista M, Carneiro F, Pinheiro H, Castedo S, Oliveira C. The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing. Cancers (Basel) 2021;13:4464. [PMID: 34503274 DOI: 10.3390/cancers13174464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
65 Figueiredo J, Mercadillo F, Melo S, Barroso A, Gonçalves M, Díaz-Tasende J, Carneiro P, Robles L, Colina F, Ibarrola C, Perea J, Morais-de-Sá E, Seruca R, Urioste M. Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers (Basel) 2021;13:4359. [PMID: 34503169 DOI: 10.3390/cancers13174359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
67 Scott N, Bennett H, Masters-Awatere B, Sarfati D, Atatoa-Carr P, Harris R. Indigenous Cancer Research: Reflections on Roles and Responsibilities. JCO Glob Oncol 2020;6:143-7. [PMID: 32031451 DOI: 10.1200/JGO.19.00124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Hoskins C, Tutty E, Purvis R, Shanahan M, Boussioutas A, Forrest L. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management. J Genet Couns 2021. [PMID: 34265132 DOI: 10.1002/jgc4.1478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Förster A, Brand F, Banan R, Hüneburg R, Weber CAM, Ewert W, Kronenberg J, Previti C, Elyan N, Beyer U, Martens H, Hong B, Bräsen JH, Erbersdobler A, Krauss JK, Stangel M, Samii A, Wolf S, Preller M, Aretz S, Wiese B, Hartmann C, Weber RG. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol 2021;142:191-210. [PMID: 33929593 DOI: 10.1007/s00401-021-02307-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers. J Laparoendosc Adv Surg Tech A 2021;31:729-37. [PMID: 34097461 DOI: 10.1089/lap.2021.0239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Rustgi SD, Ching CK, Kastrinos F. Inherited Predisposition to Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:467-87. [PMID: 34053634 DOI: 10.1016/j.giec.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
72 Te Paske IBAW, Garcia-Pelaez J, Sommer AK, Matalonga L, Starzynska T, Jakubowska A, van der Post RS, Lubinski J, Oliveira C, Hoogerbrugge N, de Voer RM; Solve-RD-GENTURIS group,. A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report. Eur J Hum Genet 2021. [PMID: 34075207 DOI: 10.1038/s41431-021-00853-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
73 Bornes L, Belthier G, van Rheenen J. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States. J Clin Med 2021;10:2403. [PMID: 34072345 DOI: 10.3390/jcm10112403] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
74 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
75 Dixon K, Brew T, Farnell D, Godwin TD, Cheung S, Chow C, Ta M, Ho G, Bui M, Douglas JM, Campbell KR, El-Naggar A, Kaurah P, Kalloger SE, Lim HJ, Schaeffer DF, Cochrane D, Guilford P, Huntsman DG. Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing. J Pathol 2021;254:254-64. [PMID: 33797756 DOI: 10.1002/path.5675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
76 Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 Germline Mutations in Non-Gastric Cancers. Cancers (Basel) 2021;13:2321. [PMID: 34066044 DOI: 10.3390/cancers13102321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
78 Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, Yokoyama A, Ogasawara T, Yamamoto Y, Yamada A, Setoyama T, Shimizu T, Kato Y, Uose S, Sakurai T, Minamiguchi S, Obama K, Sakai Y, Muto M, Chiba T, Ogawa S, Seno H. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 2021;24:1102-14. [PMID: 33961152 DOI: 10.1007/s10120-021-01191-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
79 Cui Y, Li L, Li Z, Yin J, Lane J, Ji J, Jiang WG. Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer. Cancer Cell Int 2021;21:243. [PMID: 33931048 DOI: 10.1186/s12935-021-01949-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
80 Varghese C, Immanuel T, Ruskova A, Theakston E, Kalev-Zylinska ML. The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry. Curr Oncol 2021;28:1544-57. [PMID: 33919650 DOI: 10.3390/curroncol28020146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Li D, March ME, Fortugno P, Cox LL, Matsuoka LS, Monetta R, Seiler C, Pyle LC, Bedoukian EC, Sánchez-Soler MJ, Caluseriu O, Grand K, Tam A, Aycinena ARP, Camerota L, Guo Y, Sleiman P, Callewaert B, Kumps C, Dheedene A, Buckley M, Kirk EP, Turner A, Kamien B, Patel C, Wilson M, Roscioli T, Christodoulou J, Cox TC, Zackai EH, Brancati F, Hakonarson H, Bhoj EJ. Pathogenic variants in CDH11 impair cell adhesion and cause Teebi hypertelorism syndrome. Hum Genet 2021;140:1061-76. [PMID: 33811546 DOI: 10.1007/s00439-021-02274-3] [Reference Citation Analysis]
82 Schueler SA, Gamble LA, Curtin BF, Ruff SM, Connolly M, Hannah C, Quezado M, Miettinen M, George M, Blakely AM, Hernandez JM, Heller T, Koh C, Davis JL. Evaluation of confocal laser endomicroscopy for detection of occult gastric carcinoma in CDH1 variant carriers. J Gastrointest Oncol 2021;12:216-25. [PMID: 34012620 DOI: 10.21037/jgo-20-430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
83 Gamble LA, Heller T, Davis JL. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review. JAMA Surg 2021;156:387-92. [PMID: 33404644 DOI: 10.1001/jamasurg.2020.6155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
84 Garcia-Pelaez J, Barbosa-Matos R, Gullo I, Carneiro F, Oliveira C. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges. Mol Oncol 2021. [PMID: 33724653 DOI: 10.1002/1878-0261.12948] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
85 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
86 Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, Sasaki K, Sakai R, Yamaguchi H. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis 2021;10:25. [PMID: 33677467 DOI: 10.1038/s41389-021-00314-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
87 Mentis AA, Rokkas T. Merging Helicobacter pylori eradication and family history-based genetic counseling in patients with gastric cancer: towards an overarching approach in clinical practice. Ann Gastroenterol 2021;34:451-2. [PMID: 33948075 DOI: 10.20524/aog.2021.0589] [Reference Citation Analysis]
88 Vos EL, Salo-Mullen EE, Tang LH, Schattner M, Yoon SS, Gerdes H, Markowitz AJ, Mandelker D, Janjigian Y, Offitt K, Coit DG, Stadler ZK, Strong VE. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. JAMA Surg 2020;155:1050-7. [PMID: 32997132 DOI: 10.1001/jamasurg.2020.3356] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
89 Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular Breast Cancer: A Review. Front Oncol 2020;10:591399. [PMID: 33520704 DOI: 10.3389/fonc.2020.591399] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
90 Namikawa K, Kawachi H, Tsugeno Y, Nakajima T, Fujisaki J. Detection of multiple intramucosal signet-ring cell carcinomas by white-light endoscopy and magnifying endoscopy with narrow-band imaging in a hereditary diffuse gastric cancer patient with a CDH1 germline mutation. VideoGIE 2021;6:163-6. [PMID: 33898891 DOI: 10.1016/j.vgie.2020.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Singh J, Kumar P, Verma K, Tiwary SK, Narayan G, Dixit VK. Molecular genetic changes in gastric carcinoma. IJMIO 2021;6:30-46. [DOI: 10.25259/ijmio_8_2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
92 Dilek FH, Kahraman DİA. Histopathological Findings in Prophylactic Surgical Specimens. Prophylactic Surgery 2021. [DOI: 10.1007/978-3-030-66853-2_26] [Reference Citation Analysis]
93 Irby RB, Kline CLB, Sharma AK. Regulation and Role of Par-4 in Gastrointestinal Tumors. Tumor Suppressor Par-4 2021. [DOI: 10.1007/978-3-030-80558-6_4] [Reference Citation Analysis]
94 Xiong X, Zhang P, Lu Y, He S, Zhang Y, Jia N. A dual-signal electrochemiluminescence immunosensor based on Ru(bpy)32+@3D-foam graphene and SnS2 dots for sensitive detection of gastric cancer biomarker CA 72-4. Talanta 2021;221:121644. [DOI: 10.1016/j.talanta.2020.121644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
95 Apessos A, Nasioulas G. Breast Cancer Genetics. Breast Cancer Essentials 2021. [DOI: 10.1007/978-3-030-73147-2_3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
97 Hatakeyama M. The role of Helicobacter pylori CagA oncoprotein in neoplastic transformation of gastric epithelial cells. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00005-8] [Reference Citation Analysis]
98 Gullo I, van der Post RS, Carneiro F. Recent advances in the pathology of heritable gastric cancer syndromes. Histopathology 2021;78:125-47. [PMID: 33382491 DOI: 10.1111/his.14228] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
99 Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status. Cancers (Basel) 2020;12:E3726. [PMID: 33322525 DOI: 10.3390/cancers12123726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
100 Waldum H, Mjønes P. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers (Basel) 2020;12:E3477. [PMID: 33266504 DOI: 10.3390/cancers12113477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
101 Mohammadi M. Role of Obesity in the Tumorigenesis of Gastric Cancer. Int J Prev Med 2020;11:148. [PMID: 33209218 DOI: 10.4103/ijpvm.IJPVM_153_19] [Reference Citation Analysis]
102 El Rami FE, Barsoumian HB, Khneizer GW. Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell. Ther Adv Med Oncol 2020;12:1758835920967238. [PMID: 33193828 DOI: 10.1177/1758835920967238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
103 Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J. Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature. World J Gastroenterol 2020; 26(42): 6689-6697 [PMID: 33268956 DOI: 10.3748/wjg.v26.i42.6689] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
104 Mima K, Kosumi K, Baba Y, Hamada T, Baba H, Ogino S. The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction. Hum Genet 2021;140:725-46. [PMID: 33180176 DOI: 10.1007/s00439-020-02235-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
105 Pértille F, Ibelli AMG, Sharif ME, Poleti MD, Fröhlich AS, Rezaei S, Ledur MC, Jensen P, Guerrero-Bosagna C, Coutinho LL. Putative Epigenetic Biomarkers of Stress in Red Blood Cells of Chickens Reared Across Different Biomes. Front Genet 2020;11:508809. [PMID: 33240310 DOI: 10.3389/fgene.2020.508809] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
106 Ma Z, Gao Y, Liu W, Zheng L, Jin B, Duan B, Xie H, Guo P, Zeng J, Wang K, Xu S, Wang X, He D, Li L. CD82 Suppresses ADAM17-Dependent E-Cadherin Cleavage and Cell Migration in Prostate Cancer. Dis Markers 2020;2020:8899924. [PMID: 33204367 DOI: 10.1155/2020/8899924] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
107 Djanani A. Familiäre gastrointestinale Tumorerkrankungen: daran denken! J Gastroenterol Hepatol Erkr 2020;18:95-101. [DOI: 10.1007/s41971-020-00085-3] [Reference Citation Analysis]
108 Ling Y, Watanabe Y, Nagahashi M, Shimada Y, Ichikawa H, Wakai T, Okuda S. Genetic profiling for diffuse type and genomically stable subtypes in gastric cancer. Comput Struct Biotechnol J 2020;18:3301-8. [PMID: 33240471 DOI: 10.1016/j.csbj.2020.10.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
109 Tsugeno Y, Nakano K, Nakajima T, Namikawa K, Takamatsu M, Yamamoto N, Fujisaki J, Nunobe S, Kitagawa M, Takeuchi K, Kawachi H. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Am J Surg Pathol 2020;44:1204-12. [PMID: 32520759 DOI: 10.1097/PAS.0000000000001511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
110 Corso G, Bonanni B. E-Cadherin (CDH1 Gene) Germline Mutations in Gastric Cancer: Evolutions and Innovations. Cancers (Basel) 2020;12:E2920. [PMID: 33050628 DOI: 10.3390/cancers12102920] [Reference Citation Analysis]
111 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
112 Schumacher J. Genetik des Magenkarzinoms. Onkologe 2020;26:918-926. [DOI: 10.1007/s00761-020-00806-6] [Reference Citation Analysis]
113 Landeros N, Santoro PM, Carrasco-Avino G, Corvalan AH. Competing Endogenous RNA Networks in the Epithelial to Mesenchymal Transition in Diffuse-Type of Gastric Cancer. Cancers (Basel) 2020;12:E2741. [PMID: 32987716 DOI: 10.3390/cancers12102741] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
114 Hyder Z, Fairclough A, Groom M, Getty J, Alexander E, van Veen EM, Makin G, Sethuraman C, Tang V, Evans DG, Maher ER, Woodward ER. Constitutional de novo deletion CNV encompassing REST predisposes to diffuse hyperplastic perilobar nephroblastomatosis (HPLN). J Med Genet 2021;58:581-5. [PMID: 32917767 DOI: 10.1136/jmedgenet-2020-107087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
116 Hager S, Fittler FJ, Wagner E, Bros M. Nucleic Acid-Based Approaches for Tumor Therapy. Cells 2020;9:E2061. [PMID: 32917034 DOI: 10.3390/cells9092061] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
117 Blair VR, McLeod M, Carneiro F, Coit DG, D'Addario JL, van Dieren JM, Harris KL, Hoogerbrugge N, Oliveira C, van der Post RS, Arnold J, Benusiglio PR, Bisseling TM, Boussioutas A, Cats A, Charlton A, Schreiber KEC, Davis JL, Pietro MD, Fitzgerald RC, Ford JM, Gamet K, Gullo I, Hardwick RH, Huntsman DG, Kaurah P, Kupfer SS, Latchford A, Mansfield PF, Nakajima T, Parry S, Rossaak J, Sugimura H, Svrcek M, Tischkowitz M, Ushijima T, Yamada H, Yang HK, Claydon A, Figueiredo J, Paringatai K, Seruca R, Bougen-Zhukov N, Brew T, Busija S, Carneiro P, DeGregorio L, Fisher H, Gardner E, Godwin TD, Holm KN, Humar B, Lintott CJ, Monroe EC, Muller MD, Norero E, Nouri Y, Paredes J, Sanches JM, Schulpen E, Ribeiro AS, Sporle A, Whitworth J, Zhang L, Reeve AE, Guilford P. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020;21:e386-97. [PMID: 32758476 DOI: 10.1016/S1470-2045(20)30219-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 36.3] [Reference Citation Analysis]
118 Avula LR, Hagerty B, Alewine C. Molecular mediators of peritoneal metastasis in pancreatic cancer. Cancer Metastasis Rev 2020;39:1223-43. [PMID: 32780245 DOI: 10.1007/s10555-020-09924-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
119 Devezas V, Baptista M, Gullo I, Rocha J, Sousa F, Xiaogang W, Preto J, Costa S, Castedo S, Garrido L, Oliveira C, Barbosa E, Carneiro F, Barbosa J. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. Eur Surg 2020;52:171-178. [DOI: 10.1007/s10353-020-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Iwaizumi M, Yamada H, Fukue M, Maruyama Y, Sonoda A, Sugimoto M, Koda K, Kushima R, Maekawa M, Sugimura H. Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands' endoscopic findings. Clin J Gastroenterol. 2020;13:754-758. [PMID: 32594425 DOI: 10.1007/s12328-020-01163-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Corso G, Montagna G, Figueiredo J, La Vecchia C, Fumagalli Romario U, Fernandes MS, Seixas S, Roviello F, Trovato C, Guerini-Rocco E, Fusco N, Pravettoni G, Petrocchi S, Rotili A, Massari G, Magnoni F, De Lorenzi F, Bottoni M, Galimberti V, Sanches JM, Calvello M, Seruca R, Bonanni B. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review. Cancers (Basel) 2020;12:E1598. [PMID: 32560361 DOI: 10.3390/cancers12061598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
122 Leclercq P, Jadot V, Bours V, Oliveira C, Neumann H, Bisschops R. Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch? Therap Adv Gastroenterol 2020;13:1756284820916399. [PMID: 32523621 DOI: 10.1177/1756284820916399] [Reference Citation Analysis]
123 Benesch MGK, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2020;12:E1544. [PMID: 32545410 DOI: 10.3390/cancers12061544] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
124 Samola Winnberg J, Rudd E, Keränen A, Lagerstedt-Robinson K, Lindblom A, Nilsson M, Lindblad M, Sjödahl K. Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients. Hered Cancer Clin Pract 2020;18:12. [PMID: 32518610 DOI: 10.1186/s13053-020-00145-y] [Reference Citation Analysis]
125 Ding W, Ma Y, Zhu W, Pu W, Zhang J, Qian F, Zhou Y, Deng Y, Guo S, Wang J, Zhou X. MICA 012:01 Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer. Front Genet 2020;11:511. [PMID: 32528529 DOI: 10.3389/fgene.2020.00511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
126 Niemeyer E, Mofid H, Zornig C, Burandt EC, Stein A, Block A, Volk AE. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol 2020;20:129. [PMID: 32362280 DOI: 10.1186/s12876-020-01283-2] [Reference Citation Analysis]
127 Aronson M, Swallow C, Govindarajan A, Semotiuk K, Cohen Z, Kaurah P, Velsher L, Ambus I, Buckley K, Forster-Gibson C, Meschino WS, Blumenthal A, Kim RH, Brar S. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer. Curr Oncol 2020;27:e182-90. [PMID: 32489267 DOI: 10.3747/co.27.5663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
128 Landi MT, Bishop DT, MacGregor S, Machiela MJ, Stratigos AJ, Ghiorzo P, Brossard M, Calista D, Choi J, Fargnoli MC, Zhang T, Rodolfo M, Trower AJ, Menin C, Martinez J, Hadjisavvas A, Song L, Stefanaki I, Scolyer R, Yang R, Goldstein AM, Potrony M, Kypreou KP, Pastorino L, Queirolo P, Pellegrini C, Cattaneo L, Zawistowski M, Gimenez-Xavier P, Rodriguez A, Elefanti L, Manoukian S, Rivoltini L, Smith BH, Loizidou MA, Del Regno L, Massi D, Mandala M, Khosrotehrani K, Akslen LA, Amos CI, Andresen PA, Avril MF, Azizi E, Soyer HP, Bataille V, Dalmasso B, Bowdler LM, Burdon KP, Chen WV, Codd V, Craig JE, Dębniak T, Falchi M, Fang S, Friedman E, Simi S, Galan P, Garcia-Casado Z, Gillanders EM, Gordon S, Green A, Gruis NA, Hansson J, Harland M, Harris J, Helsing P, Henders A, Hočevar M, Höiom V, Hunter D, Ingvar C, Kumar R, Lang J, Lathrop GM, Lee JE, Li X, Lubiński J, Mackie RM, Malt M, Malvehy J, McAloney K, Mohamdi H, Molven A, Moses EK, Neale RE, Novaković S, Nyholt DR, Olsson H, Orr N, Fritsche LG, Puig-Butille JA, Qureshi AA, Radford-Smith GL, Randerson-Moor J, Requena C, Rowe C, Samani NJ, Sanna M, Schadendorf D, Schulze HJ, Simms LA, Smithers M, Song F, Swerdlow AJ, van der Stoep N, Kukutsch NA, Visconti A, Wallace L, Ward SV, Wheeler L, Sturm RA, Hutchinson A, Jones K, Malasky M, Vogt A, Zhou W, Pooley KA, Elder DE, Han J, Hicks B, Hayward NK, Kanetsky PA, Brummett C, Montgomery GW, Olsen CM, Hayward C, Dunning AM, Martin NG, Evangelou E, Mann GJ, Long G, Pharoah PDP, Easton DF, Barrett JH, Cust AE, Abecasis G, Duffy DL, Whiteman DC, Gogas H, De Nicolo A, Tucker MA, Newton-Bishop JA, Peris K, Chanock SJ, Demenais F, Brown KM, Puig S, Nagore E, Shi J, Iles MM, Law MH; GenoMEL Consortium., Q-MEGA and QTWIN Investigators., ATHENS Melanoma Study Group., 23andMe., SDH Study Group., IBD Investigators., Essen-Heidelberg Investigators., AMFS Investigators., MelaNostrum Consortium. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Genet 2020;52:494-504. [PMID: 32341527 DOI: 10.1038/s41588-020-0611-8] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 23.3] [Reference Citation Analysis]
129 Wilson MM, Weinberg RA, Lees JA, Guen VJ. Emerging Mechanisms by which EMT Programs Control Stemness. Trends Cancer 2020;6:775-80. [PMID: 32312682 DOI: 10.1016/j.trecan.2020.03.011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 25.3] [Reference Citation Analysis]
130 LeBlanc S, Naveen D, Haan E, Barnett C, Rawlings L, Roscioli T, Poplawski N. CDH1-related blepharocheilodontic syndrome is associated with diffuse gastric cancer risk. Am J Med Genet A 2020;182:1780-4. [PMID: 32302040 DOI: 10.1002/ajmg.a.61601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
131 Selvanathan A, Nixon CY, Zhu Y, Scietti L, Forneris F, Uribe LMM, Lidral AC, Jezewski PA, Mulliken JB, Murray JC, Buckley MF, Cox TC, Roscioli T. CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer. Genes (Basel) 2020;11:E391. [PMID: 32260281 DOI: 10.3390/genes11040391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
132 Choi S, Jang J, Heo YJ, Kang SY, Kim ST, Lee J, Kang WK, Kim JW, Kim KM. CDH1 mutations in gastric cancers are not associated with family history. Pathol Res Pract 2020;216:152941. [PMID: 32241597 DOI: 10.1016/j.prp.2020.152941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
133 Li S, Rexin P, Qin Z, Changbo C, Guanghui C, Luyao W, Voelker HU, Stauch G. Different Incidence of Early-Onset Gastric Carcinoma Depending on Ethnicity: Preliminary Results of a Hospital in Liangshan. ScientificWorldJournal 2020;2020:6845413. [PMID: 32231466 DOI: 10.1155/2020/6845413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
135 Dibrito SR, Blair AB, Prasath V, Habibi M, Harmon JW, Duncan MD. Total Gastrectomy for CDH-1 Mutation Carriers: An Institutional Experience. Journal of Surgical Research 2020;247:438-44. [DOI: 10.1016/j.jss.2019.09.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
136 Li X, Liu J, Wang K, Zhou J, Zhang H, Zhang M, Shi Y. Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population. Pathol Res Pract 2020;216:152873. [PMID: 32107087 DOI: 10.1016/j.prp.2020.152873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Carvalho J, Oliveira P, Senz J, São José C, Hansford S, Teles SP, Ferreira M, Corso G, Pinheiro H, Lemos D, Pascale V, Roviello F, Huntsman D, Oliveira C. Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives. J Med Genet 2021;58:1-11. [PMID: 32066632 DOI: 10.1136/jmedgenet-2019-106346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
138 Venhuizen J, Jacobs FJ, Span PN, Zegers MM. P120 and E-cadherin: Double-edged swords in tumor metastasis. Seminars in Cancer Biology 2020;60:107-20. [DOI: 10.1016/j.semcancer.2019.07.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 9.7] [Reference Citation Analysis]
139 Hoang T, Ganesan AK, Hiyama D, Dayyani F. Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomas. J Gastrointest Oncol 2020;11:45-54. [PMID: 32175104 DOI: 10.21037/jgo.2019.12.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
140 Teh BT, Fearon ER. Genetic and Epigenetic Alterations in Cancer. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 209-224.e2. [DOI: 10.1016/b978-0-323-47674-4.00014-1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
141 Das UN. PUFAs and Their Metabolites in Carcinogenesis. Molecular Biochemical Aspects of Cancer 2020. [DOI: 10.1007/978-1-0716-0741-1_4] [Reference Citation Analysis]
142 Bornschein J, Quante M, Fassan M. Gastric Cancer; Epidemiology and Diagnosis. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65678-7] [Reference Citation Analysis]
143 Clauditz TS, Moore M, Setia N, Kumarasinghe M, Lauwers GY. Syndromic gastric polyposis and hereditary gastric cancers. Diagnostic Histopathology 2020;26:39-46. [DOI: 10.1016/j.mpdhp.2019.10.013] [Reference Citation Analysis]
144 Carvajal-carmona LG. Molecular Subtypes and Driver Mutations in Latinos with Gastric Cancer: Implications for Etiological and Translational Research. Advancing the Science of Cancer in Latinos 2020. [DOI: 10.1007/978-3-030-29286-7_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Walsh MF, Cadoo K, Salo-mullen EE, Dubard-gault M, Stadler ZK, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00013-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
146 Gupta MK, Rajeswari J, Reddy PR, Kumar KS, Chamundeswaramma KV, Vadde R. Genetic Marker Identification for the Detection of Early-Onset Gastric Cancer Through Genome-Wide Association Studies. Recent Advancements in Biomarkers and Early Detection of Gastrointestinal Cancers 2020. [DOI: 10.1007/978-981-15-4431-6_11] [Reference Citation Analysis]
147 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
148 Lim JH. How to Apply Genetic Analysis for Hereditary Diffuse Gastric Cancer? Korean J Helicobacter Up Gastrointest Res 2019;19:289-290. [DOI: 10.7704/kjhugr.2019.0029] [Reference Citation Analysis]
149 Webster R, Bannon SA, Hyde SM, Woodson AH, You NY, Lu KH, Arun B. Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling. Holland‐Frei Cancer Medicine 2019. [DOI: 10.1002/9781119000822.hfcm143] [Reference Citation Analysis]
150 van der Post RS, Oliveira C, Guilford P, Carneiro F. Hereditary gastric cancer: what's new? Update 2013-2018. Fam Cancer. 2019;18:363-367. [PMID: 30989426 DOI: 10.1007/s10689-019-00127-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
151 Ohyama H, Yoshimura D, Hirotsu Y, Amemiya K, Amano H, Miura Y, Ashizawa H, Nakagomi K, Takaoka S, Hosoda K, Suzuki Y, Oyama T, Hada M, Kojima Y, Mochizuki H, Omata M. Rapidly declining trend of signet ring cell cancer of the stomach may parallel the infection rate of Helicobacter pylori. BMC Gastroenterol 2019;19:178. [PMID: 31703565 DOI: 10.1186/s12876-019-1094-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
152 Yorita N, Ito M, Boda T, Kotachi T, Nagasaki N, Abuduwaili M, Hata K, Hiyama Y, Oka S, Yoshihara M, Kitadai Y, Tanaka S, Chayama K. Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer. J Gastroenterol Hepatol 2019;34:1955-62. [PMID: 31062875 DOI: 10.1111/jgh.14706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
153 Olson A, Le V, Aldahl J, Yu EJ, Hooker E, He Y, Lee DH, Kim WK, Cardiff RD, Geradts J, Sun Z. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. PLoS Genet 2019;15:e1008451. [PMID: 31658259 DOI: 10.1371/journal.pgen.1008451] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
154 Fan X, Jin S, Li Y, Khadaroo PA, Dai Y, He L, Zhou D, Lin H. Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma. Cancer Manag Res 2019;11:8947-63. [PMID: 31802937 DOI: 10.2147/CMAR.S225606] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
155 Peng Y, Wang L, Wu L, Zhang L, Nie G, Guo M. Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin. J Cancer 2019;10:6124-34. [PMID: 31762822 DOI: 10.7150/jca.32511] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
156 Vogelsang HE. Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes. Visc Med 2019;35:231-9. [PMID: 31602384 DOI: 10.1159/000501919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
157 Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, Guilford P, Corvalan AH. Identification of c.1531C>T Pathogenic Variant in the CDH1 Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2019;20:E4980. [PMID: 31600923 DOI: 10.3390/ijms20204980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
158 Tedaldi G, Pirini F, Tebaldi M, Zampiga V, Cangini I, Danesi R, Arcangeli V, Ravegnani M, Abou Khouzam R, Molinari C, Oliveira C, Morgagni P, Saragoni L, Bencivenga M, Ulivi P, Amadori D, Martinelli G, Falcini F, Ranzani GN, Calistri D. Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition. Cancers (Basel) 2019;11:E1340. [PMID: 31514334 DOI: 10.3390/cancers11091340] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
159 Roberts ME, Ranola JMO, Marshall ML, Susswein LR, Graceffo S, Bohnert K, Tsai G, Klein RT, Hruska KS, Shirts BH. Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers. JAMA Oncol 2019;5:1325-31. [PMID: 31246251 DOI: 10.1001/jamaoncol.2019.1208] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 15.3] [Reference Citation Analysis]
160 Lee K, Krempely K, Roberts ME, Anderson MJ, Carneiro F, Chao E, Dixon K, Figueiredo J, Ghosh R, Huntsman D, Kaurah P, Kesserwan C, Landrith T, Li S, Mensenkamp AR, Oliveira C, Pardo C, Pesaran T, Richardson M, Slavin TP, Spurdle AB, Trapp M, Witkowski L, Yi CS, Zhang L, Plon SE, Schrader KA, Karam R. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants. Hum Mutat 2018;39:1553-68. [PMID: 30311375 DOI: 10.1002/humu.23650] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 24.0] [Reference Citation Analysis]
161 Signal V, Gurney J, Inns S, Mcleod M, Sika-paotonu D, Sowerbutts S, Teng A, Sarfati D. Helicobacter pylori , stomach cancer and its prevention in New Zealand. Journal of the Royal Society of New Zealand 2020;50:397-417. [DOI: 10.1080/03036758.2019.1650081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Slavin TP, Weitzel JN, Neuhausen SL, Schrader KA, Oliveira C, Karam R. Genetics of gastric cancer: what do we know about the genetic risks? Transl Gastroenterol Hepatol 2019;4:55. [PMID: 31463414 DOI: 10.21037/tgh.2019.07.02] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
163 Xicola RM, Li S, Rodriguez N, Reinecke P, Karam R, Speare V, Black MH, Laduca H, Llor X. Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. J Med Genet 2019;56:838-43. [DOI: 10.1136/jmedgenet-2019-105991] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
164 Jacobs MF, Dust H, Koeppe E, Wong S, Mulholland M, Choi EY, Appelman H, Stoffel EM. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer. Gastroenterology 2019;157:87-96. [PMID: 30935944 DOI: 10.1053/j.gastro.2019.03.047] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
165 Sanjeevaiah A, Cheedella N, Hester C, Porembka MR. Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications. J Oncol Pract 2018;14:217-24. [PMID: 29641950 DOI: 10.1200/JOP.17.00025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
166 Kumar S, Long JM, Ginsberg GG, Katona BW. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. World J Gastroenterol 2019; 25(23): 2878-2886 [PMID: 31249446 DOI: 10.3748/wjg.v25.i23.2878] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
167 Liu J, Xue D, Zhu X, Yu L, Mao M, Liu Y. Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor. Invest New Drugs 2020;38:525-32. [PMID: 31183632 DOI: 10.1007/s10637-019-00799-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR. Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America. BMC Cancer 2019;19:545. [PMID: 31174492 DOI: 10.1186/s12885-019-5726-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Henare KL, Parker KE, Wihongi H, Blenkiron C, Jansen R, Reid P, Findlay MP, Lawrence B, Hudson M, Print CG. Mapping a route to Indigenous engagement in cancer genomic research. The Lancet Oncology 2019;20:e327-35. [DOI: 10.1016/s1470-2045(19)30307-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
170 Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874-883. [PMID: 30507471 DOI: 10.1016/s2468-1253(18)30237-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
171 Perrot-Applanat M, Vacher S, Pimpie C, Chemlali W, Derieux S, Pocard M, Bieche I. Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer. Oncol Lett 2019;18:674-86. [PMID: 31289541 DOI: 10.3892/ol.2019.10392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
172 Desuki A, Staib F, Gockel I, Moehler M, Lang H, Biesterfeld S, Maderer A, Galle PR, Berger MR, Schimanski CC. Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases. Can J Gastroenterol Hepatol 2019;2019:2920493. [PMID: 31058107 DOI: 10.1155/2019/2920493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
173 Hakkaart C, Ellison-Loschmann L, Day R, Sporle A, Koea J, Harawira P, Cheng S, Gray M, Whaanga T, Pearce N, Guilford P. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori. Fam Cancer 2019;18:83-90. [PMID: 29589180 DOI: 10.1007/s10689-018-0080-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
174 Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel) 2019;11:E593. [PMID: 31035365 DOI: 10.3390/cancers11050593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
175 De Scalzi AM, Bonanni B, Galimberti V, Veronesi P, Pravettoni G, Corso G. E-cadherin germline mutations in Māori population. Future Oncology 2019;15:1291-4. [DOI: 10.2217/fon-2018-0834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Kojima K, Minatani N, Ushiku H, Ishii S, Tanaka T, Yokoi K, Nishizawa N, Ooizumi Y, Igarashi K, Hosoda K, Moriya H, Mieno H, Watanabe M, Yamashita K. Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin. Oncotarget. 2019;10:2423-2434. [PMID: 31069006 DOI: 10.18632/oncotarget.26814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
177 Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil. Gastric Cancer 2019;22:920-31. [PMID: 30895400 DOI: 10.1007/s10120-019-00945-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
178 Jolly MK, Ware KE, Xu S, Gilja S, Shetler S, Yang Y, Wang X, Austin RG, Runyambo D, Hish AJ, Bartholf DeWitt S, George JT, Kreulen RT, Boss MK, Lazarides AL, Kerr DL, Gerber DG, Sivaraj D, Armstrong AJ, Dewhirst MW, Eward WC, Levine H, Somarelli JA. E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. Mol Cancer Res 2019;17:1391-402. [PMID: 30862685 DOI: 10.1158/1541-7786.MCR-18-0763] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
179 Scanlon VM, Teixeira AM, Tyagi T, Zou S, Zhang PX, Booth CJ, Kowalska MA, Bao J, Hwa J, Hayes V, Marks MS, Poncz M, Krause DS. Epithelial (E)-Cadherin is a Novel Mediator of Platelet Aggregation and Clot Stability. Thromb Haemost 2019;119:744-57. [PMID: 30861547 DOI: 10.1055/s-0039-1679908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
180 Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Liguigli W, Maglietta G, Pergola L, Ratti M, Sabadini G, Toppo L, Ungari M, Passalacqua R. Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy. BMC Cancer 2019;19:212. [PMID: 30849945 DOI: 10.1186/s12885-019-5366-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
181 Lo W, Zhu B, Sabesan A, Wu HH, Powers A, Sorber RA, Ravichandran S, Chen I, McDuffie LA, Quadri HS, Beane JD, Calzone K, Miettinen MM, Hewitt SM, Koh C, Heller T, Wacholder S, Rudloff U. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet. 2019;56:370-379. [PMID: 30745422 DOI: 10.1136/jmedgenet-2018-105361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
182 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
183 Drake J, Schreiber KC, Lopez R, Fasaye GA, Connolly M, Quezado M, Heller T, Hernandez JM, Davis JL. Establishing a center of excellence for hereditary diffuse gastric cancer syndrome. J Surg Oncol 2019;119:673-4. [PMID: 30618047 DOI: 10.1002/jso.25363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
185 Wen HY, Brogi E. Breast Cancer Pathology. Oncoplastic and Reconstructive Breast Surgery 2019. [DOI: 10.1007/978-3-319-62927-8_7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
186 Antaki F, Judd S, Kanaan Z, Patel SM, Lilley KK. Screening for Gastrointestinal Cancers. Textbook of Gastrointestinal Oncology 2019. [DOI: 10.1007/978-3-030-18890-0_32] [Reference Citation Analysis]
187 Izaguirre MF, Galetto CD, Baró L, Casco VH. E-Cadherin Dysfunction and Cancer. JBM 2019;07:42-67. [DOI: 10.4236/jbm.2019.78004] [Reference Citation Analysis]
188 De Re V, Dolcetti R. Genetic and Epigenetic Mechanisms in Gastric Cancer. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Zhang J, Qiu W, Liu H, Qian C, Liu D, Wang H, Hu N, Tang YT, Sun J, Shen Z. Genomic alterations in gastric cancers discovered via whole-exome sequencing. BMC Cancer 2018;18:1270. [PMID: 30567531 DOI: 10.1186/s12885-018-5097-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
190 Waldum HL, Fossmark R. Types of Gastric Carcinomas. Int J Mol Sci. 2018;19. [PMID: 30567376 DOI: 10.3390/ijms19124109] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
191 Nasri S, Humara B, Anjomshoaa A, Moradi N, Gholipour N, Mashjoor S, Zhang P. Early Hereditary Diffuse Gastric Cancer (eHDGC) is Characterized by Subtle Genomic Instability and Active DNA Damage Response. Pathol Oncol Res 2019;25:711-21. [PMID: 30547291 DOI: 10.1007/s12253-018-0547-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
192 van der Kaaij RT, van Kessel JP, van Dieren JM, Snaebjornsson P, Balagué O, van Coevorden F, van der Kolk LE, Sikorska K, Cats A, van Sandick JW. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. Br J Surg 2018;105:e176-82. [PMID: 29341148 DOI: 10.1002/bjs.10754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
193 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
194 Yoon JH, Kim O, Eun JW, Choi SS, Ashktorab H, Smoot DT, Nam SW, Park WS. Multiple genetic mutations caused by NKX6.3 depletion contribute to gastric tumorigenesis. Sci Rep 2018;8:17609. [PMID: 30514953 DOI: 10.1038/s41598-018-35733-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
195 Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium. J Pathol. 2019;247:35-47. [PMID: 30168144 DOI: 10.1002/path.5163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
196 Hashimoto T, Ogawa R, Tang T, Yoshida H, Taniguchi H, Katai H, Oda I, Sekine S. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Mod Pathol 2019;32:568-75. [DOI: 10.1038/s41379-018-0181-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
197 Warga RM, Kane DA. Probing Cadherin Interactions in Zebrafish with E- and N-Cadherin Missense Mutants. Genetics 2018;210:1391-409. [PMID: 30361324 DOI: 10.1534/genetics.118.301692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
198 Rocha JP, Gullo I, Wen X, Devezas V, Baptista M, Oliveira C, Carneiro F. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology 2018;73:878-86. [PMID: 30014492 DOI: 10.1111/his.13715] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
199 Wang P, Chu W, Zhang X, Li B, Wu J, Qi L, Yu Y, Zhang H. Kindlin-2 interacts with and stabilizes DNMT1 to promote breast cancer development. Int J Biochem Cell Biol 2018;105:41-51. [PMID: 30287284 DOI: 10.1016/j.biocel.2018.09.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
200 Merriman TR, Wilcox PL. Cardio-metabolic disease genetic risk factors among Māori and Pacific Island people in Aotearoa New Zealand: current state of knowledge and future directions. Ann Hum Biol 2018;45:202-14. [PMID: 29877153 DOI: 10.1080/03014460.2018.1461929] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
201 Takahashi Y, Yamamichi N, Inada KI, Shiogama K, Sakurai K, Takeuchi C, Mizutani Y, Tsutsumi Y, Koike K. Nectin1 expression is frequently decreased in gastric cancers. Pathol Int 2018;68:557-62. [PMID: 30221498 DOI: 10.1111/pin.12721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
202 Castori M, Ott CE, Bisceglia L, Leone MP, Mazza T, Castellana S, Tomassi J, Lanciotti S, Mundlos S, Hennekam RC, Kornak U, Brancati F. A novel mutation in CDH11, encoding cadherin-11, cause Branchioskeletogenital (Elsahy-Waters) syndrome. Am J Med Genet A 2018;176:2028-33. [PMID: 30194892 DOI: 10.1002/ajmg.a.40379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
203 Lyubchenko LN, Filippova MG, Anurova OA, Nazliev PB, Stilidi IS. HEREDITARY DIFFUSE GASTRIC CANCER: GENETIC ASPECTS AND PROPHYLACTIC TOTAL GASTRECTOMY. Sib onkol ž 2018;17:48-52. [DOI: 10.21294/1814-4861-2018-17-4-48-52] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
204 Moslim MA, Heald B, Tu C, Burke CA, Walsh RM. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018;164:754-759. [PMID: 30145018 DOI: 10.1016/j.surg.2018.05.059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
205 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
206 Godwin TD, Kelly ST, Brew TP, Bougen-Zhukov NM, Single AB, Chen A, Stylianou CE, Harris LD, Currie SK, Telford BJ, Beetham HG, Evans GB, Black MA, Guilford PJ. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function. Gastric Cancer 2019;22:273-86. [PMID: 30066183 DOI: 10.1007/s10120-018-0859-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
207 de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR. Molecular biology as a tool for the treatment of cancer. Clin Exp Med 2018;18:457-64. [PMID: 30006681 DOI: 10.1007/s10238-018-0518-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
208 Huang L, Yang Y, Yang F, Liu S, Zhu Z, Lei Z, Guo J. Functions of EpCAM in physiological processes and diseases (Review). Int J Mol Med. 2018;42:1771-1785. [PMID: 30015855 DOI: 10.3892/ijmm.2018.3764] [Cited by in Crossref: 45] [Cited by in F6Publishing: 60] [Article Influence: 9.0] [Reference Citation Analysis]
209 Mitsui Y, Yokoyama R, Fujimoto S, Kagemoto K, Kitamura S, Okamoto K, Muguruma N, Bando Y, Eguchi H, Okazaki Y, Ishida H, Takayama T. First report of an Asian family with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) revealed with the germline mutation of the APC exon 1B promoter region. Gastric Cancer. 2018;21:1058-1063. [PMID: 29968043 DOI: 10.1007/s10120-018-0855-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
210 van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin. 2017;10:931-945. [PMID: 29103540 DOI: 10.1016/j.path.2017.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
211 Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect. J Med Genet 2018;55:431-41. [PMID: 29929997 DOI: 10.1136/jmedgenet-2018-105337] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
212 de Groot JS, Ratze MA, van Amersfoort M, Eisemann T, Vlug EJ, Niklaas MT, Chin SF, Caldas C, van Diest PJ, Jonkers J, de Rooij J, Derksen PW. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer. J Pathol 2018;245:456-67. [PMID: 29774524 DOI: 10.1002/path.5099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
213 Strong VE. Progress in gastric cancer. Updates Surg 2018;70:157-9. [PMID: 29869781 DOI: 10.1007/s13304-018-0543-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 9.2] [Reference Citation Analysis]
214 Machlowska J, Maciejewski R, Sitarz R. The Pattern of Signatures in Gastric Cancer Prognosis. Int J Mol Sci. 2018;19. [PMID: 29867026 DOI: 10.3390/ijms19061658] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
215 Gullo I, Devezas V, Baptista M, Garrido L, Castedo S, Morais R, Wen X, Rios E, Pinheiro J, Pinto-Ribeiro I, Ferreira RM, Preto J, Santos-Antunes J, Marques M, Campos M, Almeida F, Espinheira MDC, Amil Dias J, Figueiredo C, Oliveira C, Trindade E, Carneiro F. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease. Gastrointest Endosc 2018;87:1566-75. [PMID: 29454568 DOI: 10.1016/j.gie.2018.02.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
216 Hudson M, Wilcox P, Smith B, Beaton A, Milne M, Russell K. (C)ELSI-us: Reducing Friction with Indigenous Communities in Genomic Research: World Anthropologies. American Anthropologist 2018;120:330-2. [DOI: 10.1111/aman.13043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
217 Léon JC, González-abradelo D, Strassert CA, Müller J. Fluorescent DNA-Templated Silver Nanoclusters from Silver(I)-Mediated Base Pairs. Chem Eur J 2018;24:8320-4. [DOI: 10.1002/chem.201801858] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
218 Corso G, De Scalzi A, Feroce I, Veronesi P, Bonanni B, Galimberti V. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations. Per Med 2018;15:153-5. [PMID: 29745790 DOI: 10.2217/pme-2017-0083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
219 Zollinger AJ, Xu H, Figueiredo J, Paredes J, Seruca R, Stamenović D, Smith ML. Dependence of Tensional Homeostasis on Cell Type and on Cell-Cell Interactions. Cell Mol Bioeng 2018;11:175-84. [PMID: 31719884 DOI: 10.1007/s12195-018-0527-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
220 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
221 Carvajal-Carmona LG. PALB2 as a familial gastric cancer gene: is the wait over? Lancet Gastroenterol Hepatol 2018;3:451-2. [PMID: 29706559 DOI: 10.1016/S2468-1253(18)30120-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
222 Graziano F, Ruzzo AM, Bearzi I, Testa E, Lai V, Magnani M. Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy. Tumori 2003;89:255-8. [DOI: 10.1177/030089160308900304] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
223 Zhu YP, Sheng LL, Wu J, Yang M, Cheng XF, Wu NN, Ye XB, Cai J, Wang L, Shen Q, Wu JQ. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer. Human Pathology 2018;78:28-35. [DOI: 10.1016/j.humpath.2018.04.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
224 McFarlane M, Brettschneider J, Gelsthorpe A, James S, Snead D, Gopalakrishnan K, Mehenna H, Jankowski J, Arasaradnam R, Nwokolo C. An assessment of candidate genes to assist prognosis in gastric cancer. J Gastrointest Oncol 2018;9:303-10. [PMID: 29755769 DOI: 10.21037/jgo.2018.01.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
225 Yang Y, Li X, Du J, Yin Y, Li Y. Involvement of microRNAs-MMPs-E-cadherin in the migration and invasion of gastric cancer cells infected with Helicobacter pylori. Exp Cell Res 2018;367:196-204. [PMID: 29604247 DOI: 10.1016/j.yexcr.2018.03.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
226 Bruner HC, Derksen PWB. Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer. Cold Spring Harb Perspect Biol 2018;10:a029330. [PMID: 28507022 DOI: 10.1101/cshperspect.a029330] [Cited by in Crossref: 78] [Cited by in F6Publishing: 94] [Article Influence: 15.6] [Reference Citation Analysis]
227 Kim RH, Chu QD, Li BD. Gastric Adenocarcinoma. The American Cancer Society's Oncology in Practice 2018. [DOI: 10.1002/9781118592168.ch4] [Reference Citation Analysis]
228 Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018;10:239-48. [PMID: 29445300 DOI: 10.2147/CMAR.S149619] [Cited by in Crossref: 524] [Cited by in F6Publishing: 578] [Article Influence: 104.8] [Reference Citation Analysis]
229 Mi EZ, Mi EZ, di Pietro M, O'Donovan M, Hardwick RH, Richardson S, Ziauddeen H, Fletcher PC, Caldas C, Tischkowitz M, Ragunath K, Fitzgerald RC. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Gastrointest Endosc 2018;87:408-18. [PMID: 28688938 DOI: 10.1016/j.gie.2017.06.028] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
230 Evans HM, Asher MI, Cameron-Christie S, Farthing S, McCall J, Robertson SP, Wong H, Morreau PN. Ethnic Disparity in the Incidence and Outcome of Biliary Atresia in New Zealand. J Pediatr Gastroenterol Nutr 2018;66:218-21. [PMID: 29036008 DOI: 10.1097/MPG.0000000000001781] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
231 van der Post RS, van Dieren J, Grelack A, Hoogerbrugge N, van der Kolk LE, Snaebjornsson P, Lansdorp-Vogelaar I, van Krieken JH, Bisseling TM, Cats A. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointest Endosc 2018;87:397-404.e2. [PMID: 28455161 DOI: 10.1016/j.gie.2017.04.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
232 Mi Y, Zhao S, Zhou C, Weng J, Li J, Wang Z, Sun H, Tang H, Zhang X, Sun X, Peng Z, Wen Y. Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes. Oncotarget 2016;7:60593-608. [PMID: 27533254 DOI: 10.18632/oncotarget.11260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
233 Yuxian X, Feng T, Ren L, Zhengcai L. Tanshinone II-A Inhibits Invasion and Metastasis of Human Hepatocellular Carcinoma Cells in Vitro and in Vivo. Tumori 2009;95:789-95. [DOI: 10.1177/030089160909500623] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
234 Yoshii T, Miyagi Y, Nakamura Y, Kobayashi O, Kameda Y, Ohkawa S. Pilot Research for the Correlation between the Expression Pattern of E-cadherin-β-Catenin Complex and Lymph Node Metastasis in Early Gastric Cancer. Tumori 2013;99:234-8. [DOI: 10.1177/030089161309900219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
235 Altman AM, Hui JYC, Tuttle TM. Quality-of-life implications of risk-reducing cancer surgery. British Journal of Surgery 2018;105:e121-30. [DOI: 10.1002/bjs.10725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
236 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
237 Weren RDA, van der Post RS, Vogelaar IP, van Krieken JH, Spruijt L, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Oliveira C, Kamping EJ, Schackert HK, Ranzani GN, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Cats A, Bjørnevoll I, Hoogerbrugge N, Ligtenberg MJL. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet 2018;55:669-74. [PMID: 29330337 DOI: 10.1136/jmedgenet-2017-104962] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
238 Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing. Clin Colorectal Cancer 2018;17:e293-305. [PMID: 29454559 DOI: 10.1016/j.clcc.2018.01.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
239 Lee HE, Smyrk TC, Zhang L. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Hum Pathol 2018;74:64-72. [PMID: 29307626 DOI: 10.1016/j.humpath.2017.12.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
240 Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 2018;122:179-93. [PMID: 29458786 DOI: 10.1016/j.critrevonc.2017.12.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
241 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease 2018. [DOI: 10.1016/b978-0-12-812215-0.00021-2] [Reference Citation Analysis]
242 Sepulveda AR, J. Del Portillo A. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
243 Zhang H, Feng M, Feng Y, Bu Z, Li Z, Jia S, Ji J. Germline mutations in hereditary diffuse gastric cancer. Chin J Cancer Res 2018;30:122-30. [PMID: 29545726 DOI: 10.21147/j.issn.1000-9604.2018.01.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
244 Barra WF, Demachki S, Ishak G, de Assumpção PP. Epidemiology. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_2] [Reference Citation Analysis]
245 Biswas KH, Groves JT. Spatial and Mechanical Aspects of Signal Transduction in the Cell Membrane. Physics of Biological Membranes 2018. [DOI: 10.1007/978-3-030-00630-3_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
246 Coleman WB. Neoplasia. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00004-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
247 Chornobai A, Chornobai M, My�soedov S, Sorokin B. POLYMORPHISM OF GENES AS A CAUSE OF GENETIC RISK FACTORS FOR MALIGNANT NEOPLASMS. VPBM 2018;1.2:46. [DOI: 10.29254/2077-4214-2018-1-2-143-46-51] [Reference Citation Analysis]
248 de Gouvea ACRC, Silva ACB, Victor CR, Mendoza EZ, Nardo M, Guindalini RSC. Genetic Predisposition and Hereditary Syndromes. Diffuse Gastric Cancer 2018. [DOI: 10.1007/978-3-319-95234-5_5] [Reference Citation Analysis]
249 Carley H, Kulkarni A. Hereditary Breast Cancer Genetics and Risk Prediction Techniques. Breast Cancer Management for Surgeons 2018. [DOI: 10.1007/978-3-319-56673-3_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
250 Youssef O, Sarhadi V, Ehsan H, Böhling T, Carpelan-Holmström M, Koskensalo S, Puolakkainen P, Kokkola A, Knuutila S. Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing. World J Gastroenterol 2017; 23(47): 8291-8299 [PMID: 29307989 DOI: 10.3748/wjg.v23.i47.8291] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
251 Marotti JD, Schnitt SJ. Genotype-Phenotype Correlations in Breast Cancer. Surg Pathol Clin 2018;11:199-211. [PMID: 29413657 DOI: 10.1016/j.path.2017.09.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
252 Melo S, Figueiredo J, Fernandes MS, Gonçalves M, Morais-de-Sá E, Sanches JM, Seruca R. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2017;18:E2687. [PMID: 29231860 DOI: 10.3390/ijms18122687] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
253 Wen HY, Brogi E. Lobular Carcinoma In Situ. Surg Pathol Clin 2018;11:123-45. [PMID: 29413653 DOI: 10.1016/j.path.2017.09.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
254 Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Mullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients. Ann Surg 2017;266:1006-12. [PMID: 27759617 DOI: 10.1097/SLA.0000000000002030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
255 Powers B, Pal T, Laronga C. Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine. Surg Oncol Clin N Am 2018;27:1-22. [PMID: 29132555 DOI: 10.1016/j.soc.2017.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
256 Cárdenas-Mondragón MG, Torres J, Sánchez-Zauco N, Gómez-Delgado A, Camorlinga-Ponce M, Maldonado-Bernal C, Fuentes-Pananá EM. Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer. J Immunol Res 2017;2017:7069242. [PMID: 29349089 DOI: 10.1155/2017/7069242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
257 VanderVorst K, Hatakeyama J, Berg A, Lee H, Carraway KL 3rd. Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy. Semin Cell Dev Biol 2018;81:78-87. [PMID: 29107170 DOI: 10.1016/j.semcdb.2017.09.026] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
258 Kelly NJ, Varga JFA, Specker EJ, Romeo CM, Coomber BL, Uniacke J. Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion. Oncogene 2018;37:651-62. [PMID: 28991229 DOI: 10.1038/onc.2017.372] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
259 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
260 Shashikanth N, Yeruva S, Ong MLDM, Odenwald MA, Pavlyuk R, Turner JR. Epithelial Organization: The Gut and Beyond. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1497-518. [DOI: 10.1002/cphy.c170003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
261 Vogelaar IP, van der Post RS, van Krieken JHJ, Spruijt L, van Zelst-Stams WA, Kets CM, Lubinski J, Jakubowska A, Teodorczyk U, Aalfs CM, van Hest LP, Pinheiro H, Oliveira C, Jhangiani SN, Muzny DM, Gibbs RA, Lupski JR, de Ligt J, Vissers LELM, Hoischen A, Gilissen C, van de Vorst M, Goeman JJ, Schackert HK, Ranzani GN, Molinaro V, Gómez García EB, Hes FJ, Holinski-Feder E, Genuardi M, Ausems MGEM, Sijmons RH, Wagner A, van der Kolk LE, Bjørnevoll I, Høberg-Vetti H, van Kessel AG, Kuiper RP, Ligtenberg MJL, Hoogerbrugge N. Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing. Eur J Hum Genet 2017;25:1246-52. [PMID: 28875981 DOI: 10.1038/ejhg.2017.138] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
262 Bornschein J, Schlosser S. Pathogenese und Prävention des Magenkarzinoms. Gastroenterologe 2017;12:365-375. [DOI: 10.1007/s11377-017-0189-6] [Reference Citation Analysis]
263 Ghersin I, Katz LH. Gastric cancer in a teenager: a case report. Int J Adolesc Med Health 2017;31:/j/ijamh. [PMID: 28779571 DOI: 10.1515/ijamh-2017-0078] [Reference Citation Analysis]
264 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
265 Ellison-Loschmann L, Sporle A, Corbin M, Cheng S, Harawira P, Gray M, Whaanga T, Guilford P, Koea J, Pearce N. Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study. PLoS One 2017;12:e0181581. [PMID: 28732086 DOI: 10.1371/journal.pone.0181581] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
266 Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol 2017;174:4666-83. [PMID: 28568899 DOI: 10.1111/bph.13890] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
267 Ma YR, Ren Z, Conner MG, Siegal GP, Wei S. Reduced E-Cadherin and Aberrant β-Catenin Expression are Associated With Advanced Disease in Signet-Ring Cell Carcinomas. Applied Immunohistochemistry & Molecular Morphology 2017;25:432-8. [DOI: 10.1097/pai.0000000000000317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
268 Mathew A, Rajagopal PS, Villgran V, Sandhu GS, Jankowitz RC, Jacob M, Rosenzweig M, Oesterreich S, Brufsky A. Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast. Geburtshilfe Frauenheilkd 2017;77:660-6. [PMID: 28757653 DOI: 10.1055/s-0043-109374] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
269 Santamaria PG, Moreno-Bueno G, Portillo F, Cano A. EMT: Present and future in clinical oncology. Mol Oncol 2017;11:718-38. [PMID: 28590039 DOI: 10.1002/1878-0261.12091] [Cited by in Crossref: 138] [Cited by in F6Publishing: 159] [Article Influence: 23.0] [Reference Citation Analysis]
270 De Mello RA. Gastric Cancer in Southern Europe: High-Risk Disease. Am Soc Clin Oncol Educ Book 2017;37:261-6. [PMID: 28561674 DOI: 10.1200/EDBK_175227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
271 Hayakawa Y, Sethi N, Sepulveda AR, Bass AJ, Wang TC. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer. 2016;16:305-318. [PMID: 27112208 DOI: 10.1038/nrc.2016.24] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 12.8] [Reference Citation Analysis]
272 Prieto-García E, Díaz-García CV, García-Ruiz I, Agulló-Ortuño MT. Epithelial-to-mesenchymal transition in tumor progression. Med Oncol 2017;34:122. [PMID: 28560682 DOI: 10.1007/s12032-017-0980-8] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
273 Singh DR, Ahmed F, Sarabipour S, Hristova K. Intracellular Domain Contacts Contribute to Ecadherin Constitutive Dimerization in the Plasma Membrane. J Mol Biol 2017;429:2231-45. [PMID: 28549925 DOI: 10.1016/j.jmb.2017.05.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
274 Langner C. Hereditäres Magen- und Pankreaskarzinom. Pathologe 2017;38:164-9. [DOI: 10.1007/s00292-017-0297-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
275 Chen I, Mathews-Greiner L, Li D, Abisoye-Ogunniyan A, Ray S, Bian Y, Shukla V, Zhang X, Guha R, Thomas C, Gryder B, Zacharia A, Beane JD, Ravichandran S, Ferrer M, Rudloff U. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med 2017;15:92. [PMID: 28460635 DOI: 10.1186/s12967-017-1197-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
276 Goldenring JR. The AGA/Funderburg Award in Gastric Cancer: Twenty-five Years of Advances in Gastric Cancer Research. Gastroenterology 2017;152:1262-6. [PMID: 28327368 DOI: 10.1053/j.gastro.2017.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
277 Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:196-219. [PMID: 28413197 DOI: 10.2183/pjab.93.013] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 16.0] [Reference Citation Analysis]
278 Strand MS, Lockhart AC, Fields RC. Genetics of Gastric Cancer. Surg Clin North Am. 2017;97:345-370. [PMID: 28325191 DOI: 10.1016/j.suc.2016.11.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
279 Yaghoobi M, McNabb-Baltar J, Bijarchi R, Hunt RH. What is the quantitative risk of gastric cancer in the first-degree relatives of patients? A meta-analysis. World J Gastroenterol 2017; 23(13): 2435-2442 [PMID: 28428723 DOI: 10.3748/wjg.v23.i13.2435] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
280 Sahasrabudhe R, Lott P, Bohorquez M, Toal T, Estrada AP, Suarez JJ, Brea-Fernández A, Cameselle-Teijeiro J, Pinto C, Ramos I, Mantilla A, Prieto R, Corvalan A, Norero E, Alvarez C, Tapia T, Carvallo P, Gonzalez LM, Cock-Rada A, Solano A, Neffa F, Della Valle A, Yau C, Soares G, Borowsky A, Hu N, He LJ, Han XY, Taylor PR, Goldstein AM, Torres J, Echeverry M, Ruiz-Ponte C, Teixeira MR, Carvajal-Carmona LG; Latin American Gastric Cancer Genetics Collaborative Group. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer. Gastroenterology 2017;152:983-986.e6. [PMID: 28024868 DOI: 10.1053/j.gastro.2016.12.010] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 11.2] [Reference Citation Analysis]
281 Kupfer SS. Gaining Ground in the Genetics of Gastric Cancer. Gastroenterology 2017;152:926-8. [PMID: 28257979 DOI: 10.1053/j.gastro.2017.02.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
282 Panarese I, De Vita F, Ronchi A, Romano M, Alfano R, Di Martino N, Zito Marino F, Ferraraccio F, Franco R. Predictive biomarkers along gastric cancer pathogenetic pathways. Expert Rev Anticancer Ther 2017;17:417-25. [PMID: 28277834 DOI: 10.1080/14737140.2017.1301207] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
283 Boland CR, Yurgelun MB. Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:192-200. [PMID: 28275686 DOI: 10.1016/j.jcmgh.2016.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
284 Waldum HL, Sagatun L, Mjønes P. Gastrin and Gastric Cancer. Front Endocrinol (Lausanne) 2017;8:1. [PMID: 28144230 DOI: 10.3389/fendo.2017.00001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
285 Sheng L, Zhang S, Xu H. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells. Med Sci Monit 2017;23:138-43. [PMID: 28070118 DOI: 10.12659/msm.902725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
286 France MM, Turner JR. The mucosal barrier at a glance. J Cell Sci 2017;130:307-14. [PMID: 28062847 DOI: 10.1242/jcs.193482] [Cited by in Crossref: 110] [Cited by in F6Publishing: 129] [Article Influence: 18.3] [Reference Citation Analysis]
287 Li L, Fan X. Molecular Pathology of Heredity Gastric Cancer. Personalized Management of Gastric Cancer 2017. [DOI: 10.1007/978-981-10-3978-2_1] [Reference Citation Analysis]
288 Schumacher J. Familiäre Magenkarzinome. Moderne Chirurgie des Magen- und Kardiakarzinoms 2017. [DOI: 10.1007/978-3-662-53188-4_3] [Reference Citation Analysis]
289 de Gouvea ACRC, Garber JE. Breast Cancer Genetics. Breast Cancer 2017. [DOI: 10.1007/978-3-319-48848-6_8] [Reference Citation Analysis]
290 Richman DM, Tirumani SH, Hornick JL, Fuchs CS, Howard S, Krajewski K, Ramaiya N, Rosenthal M. Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms. Abdom Radiol (NY) 2017;42:124-40. [PMID: 27645897 DOI: 10.1007/s00261-016-0901-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
291 Bleyer A. Other Carcinomas. Cancer in Adolescents and Young Adults 2017. [DOI: 10.1007/978-3-319-33679-4_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
292 Xu K. DNA and Histone Methylation in Prostate Cancer. DNA and Histone Methylation as Cancer Targets 2017. [DOI: 10.1007/978-3-319-59786-7_18] [Reference Citation Analysis]
293 van der Post CRS, Carneiro F. E-Cadherin, Hereditary Diffuse Gastric Cancer. Encyclopedia of Pathology 2017. [DOI: 10.1007/978-3-319-40560-5_1586] [Reference Citation Analysis]
294 Corso G, Intra M, Trentin C, Veronesi P, Galimberti V. CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer. 2016;15:215-219. [PMID: 26759166 DOI: 10.1007/s10689-016-9869-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 10.3] [Reference Citation Analysis]
295 Brandão C, Dinis-Ribeiro M. Early diagnosis of hereditary diffuse gastric cancer: (not only) an endoscopic challenge! Endosc Int Open 2016;4:E1311-2. [PMID: 27995194 DOI: 10.1055/s-0042-121003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
296 Kataoka K, Ogawa S. Variegated RHOA mutations in human cancers. Experimental Hematology 2016;44:1123-9. [DOI: 10.1016/j.exphem.2016.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
297 Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life. J Gastrointest Surg 2016;20:1950-8. [PMID: 27752808 DOI: 10.1007/s11605-016-3287-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
298 Yelskaya Z, Bacares R, Salo-Mullen E, Somar J, Lehrich DA, Fasaye GA, Coit DG, Tang LH, Stadler ZK, Zhang L. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site. PLoS One. 2016;11:e0165654. [PMID: 27880784 DOI: 10.1371/journal.pone.0165654] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
299 Huang B, Ni M, Chen C, Feng Y, Cai S. Younger Age Is Associated with Poorer Survival in Patients with Signet-Ring Cell Carcinoma of the Colon without Distant Metastasis. Gastroenterol Res Pract 2016;2016:2913493. [PMID: 27994618 DOI: 10.1155/2016/2913493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
300 Ma YR, Siegal GP, Wei S. Reacquisition of E-cadherin expression in metastatic deposits of signet-ring cell carcinoma of the upper gastrointestinal system: a potential anchor for metastatic deposition. J Clin Pathol 2017;70:528-32. [PMID: 27864451 DOI: 10.1136/jclinpath-2016-203959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
301 Yu SR, Huang XJ, Zhang YP. Gastric cancer related genes. Shijie Huaren Xiaohua Zazhi 2016; 24(32): 4381-4388 [DOI: 10.11569/wcjd.v24.i32.4381] [Reference Citation Analysis]
302 Okuda T, Taki T, Nishida K, Chinen Y, Nagoshi H, Sakakura C, Taniwaki M. Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26. Oncol Lett 2017;13:215-21. [PMID: 28123544 DOI: 10.3892/ol.2016.5386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
303 Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol 2017;10:13-7. [PMID: 27783218 DOI: 10.1007/s12328-016-0696-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
304 Pantelis D, Hüneburg R, Adam R, Holzapfel S, Gevensleben H, Nattermann J, Strassburg CP, Aretz S, Kalff JC. Prophylactic total gastrectomy in the management of hereditary tumor syndromes. Int J Colorectal Dis 2016;31:1825-33. [PMID: 27682646 DOI: 10.1007/s00384-016-2656-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
305 Beaton A, Hudson M, Milne M, Port RV, Russell K, Smith B, Toki V, Uerata L, Wilcox P, Bartholomew K, Wihongi H. Engaging Māori in biobanking and genomic research: a model for biobanks to guide culturally informed governance, operational, and community engagement activities. Genet Med 2017;19:345-51. [DOI: 10.1038/gim.2016.111] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
306 Tashiro E, Henmi S, Odake H, Ino S, Imoto M. Involvement of the MEK/ERK pathway in EGF-induced E-cadherin down-regulation. Biochemical and Biophysical Research Communications 2016;477:801-6. [DOI: 10.1016/j.bbrc.2016.06.138] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
307 Hüneburg R, Marwitz T, van Heteren P, Weismüller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. Endosc Int Open 2016;4:E1305-10. [PMID: 27995193 DOI: 10.1055/s-0042-112582] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
308 Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27:3233-3244. [PMID: 27582386 DOI: 10.1091/mbc.e16-01-0058] [Cited by in Crossref: 140] [Cited by in F6Publishing: 153] [Article Influence: 20.0] [Reference Citation Analysis]
309 Nishi E, Masuda K, Arakawa M, Kawame H, Kosho T, Kitahara M, Kubota N, Hidaka E, Katoh Y, Shirahige K, Izumi K. Exome sequencing-based identification of mutations in non-syndromic genes among individuals with apparently syndromic features. Am J Med Genet A 2016;170:2889-94. [PMID: 27566442 DOI: 10.1002/ajmg.a.37826] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
310 Hugen S, Thomas RE, German AJ, Burgener IA, Mandigers PJJ. Gastric carcinoma in canines and humans, a review. Vet Comp Oncol 2017;15:692-705. [PMID: 27549077 DOI: 10.1111/vco.12249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
311 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
312 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. Hereditary gastric and pancreatic cancer predisposition syndromes. Gastroenterología y Hepatología (English Edition) 2016;39:481-93. [DOI: 10.1016/j.gastre.2016.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
313 Tenhagen M, Klarenbeek S, Braumuller TM, Hofmann I, van der Groep P, Ter Hoeve N, van der Wall E, Jonkers J, Derksen PW. p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice. J Mammary Gland Biol Neoplasia 2016;21:81-8. [PMID: 27411687 DOI: 10.1007/s10911-016-9358-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
314 Reeve J, Owens RG, Winship IM. Psychological Impact of Predictive Testing for Colonic Cancer. J Health Psychol 2000;5:99-108. [DOI: 10.1177/135910530000500102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
315 Johnston N, Bulmer D, Ross PE, Axford SE, Gill GA, Pearson JP, Dettmar PW, Panetti M, Pignatelli M, Koufman JA. Cell Biology of Laryngeal Epithelial Defenses in Health and Disease: Further Studies. Ann Otol Rhinol Laryngol 2003;112:481-91. [DOI: 10.1177/000348940311200601] [Cited by in Crossref: 145] [Cited by in F6Publishing: 149] [Article Influence: 20.7] [Reference Citation Analysis]
316 Rankine J, Mccreanor T. Colonial Coverage: Media Reporting of a Bicultural Health Research Partnership. Journalism 2004;5:5-29. [DOI: 10.1177/1464884904040397] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
317 Correa P, Piazuelo MB, Camargo MC. Etiopathogenesis of Gastric Cancer. Scand J Surg 2006;95:218-24. [DOI: 10.1177/145749690609500402] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
318 El-Husny A, Raiol-Moraes M, Amador M, Ribeiro-Dos-Santos AM, Montagnini A, Barbosa S, Silva A, Assumpção P, Ishak G, Santos S, Pinto P, Cruz A, Ribeiro-Dos-Santos Â. CDH1 mutations in gastric cancer patients from northern Brazil identified by Next- Generation Sequencing (NGS). Genet Mol Biol 2016;39:189-98. [PMID: 27192129 DOI: 10.1590/1678-4685-GMB-2014-0342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
319 Ittiwut R, Ittiwut C, Siriwan P, Chichareon V, Suphapeetiporn K, Shotelersuk V. Variants of the CDH1 (E-Cadherin) Gene Associated with Oral Clefts in the Thai Population. Genet Test Mol Biomarkers 2016;20:406-9. [PMID: 27227907 DOI: 10.1089/gtmb.2015.0325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
320 Mestre T, Figueiredo J, Ribeiro AS, Paredes J, Seruca R, Sanches JM. Quantification of topological features in cell meshes to explore E-cadherin dysfunction. Sci Rep 2016;6:25101. [PMID: 27151223 DOI: 10.1038/srep25101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
321 Goodman RP, Chung DC. Clinical Genetic Testing in Gastroenterology. Clin Transl Gastroenterol 2016;7:e167. [PMID: 27124700 DOI: 10.1038/ctg.2016.23] [Reference Citation Analysis]
322 Powell AG, Hughes DL, Wheat JR, Lewis WG. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. International Journal of Surgery 2016;28:83-90. [DOI: 10.1016/j.ijsu.2016.02.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
323 Schmidt TP, Perna AM, Fugmann T, Böhm M, Jan Hiss, Haller S, Götz C, Tegtmeyer N, Hoy B, Rau TT, Neri D, Backert S, Schneider G, Wessler S. Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep 2016;6:23264. [PMID: 26983597 DOI: 10.1038/srep23264] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
324 Caceres G, Puskas JA, Magliocco AM. Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness. Cancer Control 2015;22:167-76. [PMID: 26068761 DOI: 10.1177/107327481502200207] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
325 Gonzalez RS, Riddle ND. Syndrome-Associated Tumors by Organ System. J Pediatr Genet 2016;5:105-15. [PMID: 27617151 DOI: 10.1055/s-0036-1580597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
326 Lordick F, Janjigian YY. Clinical impact of tumour biology in the management of gastroesophageal cancer. Nat Rev Clin Oncol. 2016;13:348-360. [PMID: 26925958 DOI: 10.1038/nrclinonc.2016.15] [Cited by in Crossref: 93] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
327 Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18. [PMID: 26905733 DOI: 10.1186/s12943-016-0502-x] [Cited by in Crossref: 328] [Cited by in F6Publishing: 379] [Article Influence: 46.9] [Reference Citation Analysis]
328 Leoz ML, Sánchez A, Carballal S, Ruano L, Ocaña T, Pellisé M, Castells A, Balaguer F, Moreira L. [Hereditary gastric and pancreatic cancer predisposition syndromes]. Gastroenterol Hepatol 2016;39:481-93. [PMID: 26916701 DOI: 10.1016/j.gastrohep.2015.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
329 Ławniczak M, Jakubowska A, Białek A, Lubiński J, Jaworska-Bieniek K, Kaczmarek K, Starzyńska T. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population. Hered Cancer Clin Pract 2016;14:3. [PMID: 26779294 DOI: 10.1186/s13053-015-0043-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
330 Huynh JM, Laukaitis CM. Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer. Mol Genet Genomic Med. 2016;4:232-236. [PMID: 27064202 DOI: 10.1002/mgg3.197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
331 Sekine S, Yoshida H, Jansen M, Kushima R. The Japanese Viewpoint on the Histopathology of Early Gastric Cancer. Adv Exp Med Biol 2016;908:331-46. [PMID: 27573779 DOI: 10.1007/978-3-319-41388-4_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
332 Reis CA. Gastric Cancer. Encyclopedia of Cancer 2016. [DOI: 10.1007/978-3-662-46875-3_2329] [Reference Citation Analysis]
333 Walsh MF, Nathanson KL, Couch FJ, Offit K. Genomic Biomarkers for Breast Cancer Risk. Adv Exp Med Biol 2016;882:1-32. [PMID: 26987529 DOI: 10.1007/978-3-319-22909-6_1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
334 Gumbiner BM. Classical Cadherins. The Cadherin Superfamily 2016. [DOI: 10.1007/978-4-431-56033-3_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
335 Kramer IM. WNT Signaling and the Regulation of Cell Adhesion and Differentiation. Signal Transduction 2016. [DOI: 10.1016/b978-0-12-394803-8.00012-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
336 Hirano S, Imai-okano K. Cadherin-Related Diseases. The Cadherin Superfamily 2016. [DOI: 10.1007/978-4-431-56033-3_15] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
337 Reis CA, Magalhães A. Glycosyltransferases and Gastric Cancer. Glycosignals in Cancer: Mechanisms of Malignant Phenotypes 2016. [DOI: 10.1007/978-4-431-55939-9_2] [Reference Citation Analysis]
338 van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Adv Exp Med Biol 2016;908:371-91. [PMID: 27573781 DOI: 10.1007/978-3-319-41388-4_18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
339 Hwang H, Sahoo S. Invasive Lobular Carcinoma. A Comprehensive Guide to Core Needle Biopsies of the Breast 2016. [DOI: 10.1007/978-3-319-26291-8_15] [Reference Citation Analysis]
340 Hata K, Yamamoto Y, Kiyomatsu T, Tanaka T, Kazama S, Nozawa H, Kawai K, Tanaka J, Nishikawa T, Otani K. Hereditary gastrointestinal cancer. Surg Today. 2015; Dec 16. [Epub ahead of print]. [PMID: 26676416 DOI: 10.1007/s00595-015-1283-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
341 Turner JR. Epithelia and Gastrointestinal Function. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
342 Wang X, Ren Y, Yang X, Xiong X, Han S, Ge Y, Pan W, Zhou L, Yuan Q, Yang M. miR-190a inhibits epithelial-mesenchymal transition of hepatoma cells via targeting the long non-coding RNA treRNA. FEBS Lett. 2015;589:4079-4087. [PMID: 26608035 DOI: 10.1016/j.febslet.2015.11.024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
343 Hayakawa Y, Ariyama H, Stancikova J, Sakitani K, Asfaha S, Renz BW, Dubeykovskaya ZA, Shibata W, Wang H, Westphalen CB, Chen X, Takemoto Y, Kim W, Khurana SS, Tailor Y, Nagar K, Tomita H, Hara A, Sepulveda AR, Setlik W, Gershon MD, Saha S, Ding L, Shen Z, Fox JG, Friedman RA, Konieczny SF, Worthley DL, Korinek V, Wang TC. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. Cancer Cell. 2015;28:800-814. [PMID: 26585400 DOI: 10.1016/j.ccell.2015.10.003] [Cited by in Crossref: 198] [Cited by in F6Publishing: 179] [Article Influence: 24.8] [Reference Citation Analysis]
344 Preda V, Larkin SJ, Karavitaki N, Ansorge O, Grossman AB. The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. Endocr Pathol 2015;26:1-8. [PMID: 25355426 DOI: 10.1007/s12022-014-9341-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
345 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 169] [Article Influence: 19.1] [Reference Citation Analysis]
346 Hudler P. Challenges of deciphering gastric cancer heterogeneity. World J Gastroenterol 2015; 21(37): 10510-10527 [PMID: 26457012 DOI: 10.3748/wjg.v21.i37.10510] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
347 van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology 2015;149:897-906.e19. [PMID: 26072394 DOI: 10.1053/j.gastro.2015.06.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
348 Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT, Lauwers GY. Familial Gastric Cancers. Oncologist. 2015;20:1365-1377. [PMID: 26424758 DOI: 10.1634/theoncologist.2015-0205] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
349 Tan RYC, Ngeow J. Hereditary diffuse gastric cancer: What the clinician should know. World J Gastrointest Oncol 2015; 7(9): 153-160 [PMID: 26380059 DOI: 10.4251/wjgo.v7.i9.153] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
350 Chikman B, Davidson T, Kais H, Jeroukhimov I, Leshno A, Sandbank J, Halevy A, Lavy R. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? Familial Cancer 2016;15:41-7. [DOI: 10.1007/s10689-015-9833-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
351 Cárdenas-Mondragón MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, Carreón-Talavera R, Gomez-Delgado A, Kasamatsu E, Fuentes-Pananá EM. Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Br J Cancer 2015;112:1866-73. [PMID: 25996206 DOI: 10.1038/bjc.2015.175] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
352 Thomas RM, Jobin C. The Microbiome and Cancer: Is the 'Oncobiome' Mirage Real? Trends Cancer 2015;1:24-35. [PMID: 26568984 DOI: 10.1016/j.trecan.2015.07.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
353 Caldeira J, Figueiredo J, Brás-Pereira C, Carneiro P, Moreira AM, Pinto MT, Relvas JB, Carneiro F, Barbosa M, Casares F, Janody F, Seruca R. E-cadherin-defective gastric cancer cells depend on Laminin to survive and invade. Hum Mol Genet 2015;24:5891-900. [PMID: 26246502 DOI: 10.1093/hmg/ddv312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
354 Klinke DJ 2nd, Horvath N, Cuppett V, Wu Y, Deng W, Kanj R. Interlocked positive and negative feedback network motifs regulate β-catenin activity in the adherens junction pathway. Mol Biol Cell 2015;26:4135-48. [PMID: 26224311 DOI: 10.1091/mbc.E15-02-0083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
355 Colvin H, Yamamoto K, Wada N, Mori M. Hereditary Gastric Cancer Syndromes. Surg Oncol Clin N Am 2015;24:765-77. [PMID: 26363540 DOI: 10.1016/j.soc.2015.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
356 Sunakawa Y, Lenz HJ. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Curr Treat Options Oncol. 2015;16:17. [PMID: 25813036 DOI: 10.1007/s11864-015-0331-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
357 Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc 2015;27:551-61. [PMID: 25807972 DOI: 10.1111/den.12471] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 9.1] [Reference Citation Analysis]
358 Gurzu S, Jung I, Orlowska J, Sugimura H, Kadar Z, Turdean S, Bara T. Hereditary diffuse gastric cancer--An overview. Pathol Res Pract. 2015;211:629-632. [PMID: 26150395 DOI: 10.1016/j.prp.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
359 Sugimoto S, Komatsu H, Morohoshi Y, Kanai T. Recognition of and recent issues in hereditary diffuse gastric cancer. J Gastroenterol. 2015;50:831-843. [PMID: 26049741 DOI: 10.1007/s00535-015-1093-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
360 Waldum HL, Hauso Ø, Sørdal ØF, Fossmark R. Gastrin May Mediate the Carcinogenic Effect of Helicobacter pylori Infection of the Stomach. Dig Dis Sci 2015;60:1522-7. [PMID: 25480404 DOI: 10.1007/s10620-014-3468-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
361 Zendejas B, Zarroug AE, Kendrick ML. Laparoscopic Prophylactic Total Gastrectomy in Childhood for the Prevention of Hereditary Diffuse Gastric Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques Part B, Videoscopy 2015;25:vor.2014.0221. [DOI: 10.1089/vor.2014.0221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
362 van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361-374. [PMID: 25979631 DOI: 10.1136/jmedgenet-2015-103094] [Cited by in Crossref: 365] [Cited by in F6Publishing: 387] [Article Influence: 45.6] [Reference Citation Analysis]
363 Lajus TB, Sales RM. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer. Gene 2015;568:215-9. [PMID: 25981591 DOI: 10.1016/j.gene.2015.05.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
364 Cito L, Indovina P, Forte IM, Pentimalli F, Di Marzo D, Somma P, Barone D, Penon A, Penon D, Ceccherini E, Micheli P, Saragoni L, Di Domenico M, Feola A, Roviello F, Mattioli E, Giordano GG, Giordano A. pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer. J Cell Physiol 2015;230:802-5. [PMID: 25205458 DOI: 10.1002/jcp.24805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
365 Kwak HW, Choi IJ, Kim CG, Lee JY, Cho SJ, Eom BW, Yoon HM, Joo J, Ryu KW, Kim YW. Individual having a parent with early-onset gastric cancer may need screening at younger age. World J Gastroenterol 2015; 21(15): 4592-4598 [PMID: 25914468 DOI: 10.3748/wjg.v21.i15.4592] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
366 Bonadies DC, Brierley KL, Barnett RE, Baxter MD, Donenberg T, Ducaine WL, Ernst ME, Homer J, Judkins M, Lovick NM, Powers JM, Stanislaw C, Stark E, Stenner RC, Matloff ET. Adverse events in cancer genetic testing: the third case series. Cancer J 2014;20:246-53. [PMID: 25098283 DOI: 10.1097/PPO.0000000000000057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
367 Dong L, Deng J, Sun ZM, Pan AP, Xiang XJ, Zhang L, Yu F, Chen J, Sun Z, Feng M, Xiong JP. Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile. Tumour Biol 2015;36:6973-83. [PMID: 25861021 DOI: 10.1007/s13277-015-3415-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
368 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16:e60-e70. [PMID: 25638682 DOI: 10.1016/s1470-2045(14)71016-2] [Cited by in Crossref: 219] [Cited by in F6Publishing: 173] [Article Influence: 27.4] [Reference Citation Analysis]
369 Sani IK, Marashi SH, Kalalinia F. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. Toxicol In Vitro 2015;29:893-900. [PMID: 25819016 DOI: 10.1016/j.tiv.2015.03.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
370 Pinheiro H, Oliveira P, Oliveira C. Hereditary Cancer Risk Assessment: Challenges for the Next-Gen Sequencing Era. Front Oncol 2015;5. [DOI: 10.3389/fonc.2015.00062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
371 Datta De D, Roychoudhury S. To be or not to be: The host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases. World J Gastroenterol 2015; 21(10): 2883-2895 [PMID: 25780285 DOI: 10.3748/wjg.v21.i10.2883] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
372 Bellizzi AM, Hornick JL. The stomach. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.026] [Reference Citation Analysis]
373 Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 2015;17:37. [PMID: 25848941 DOI: 10.1186/s13058-015-0546-7] [Cited by in Crossref: 89] [Cited by in F6Publishing: 98] [Article Influence: 11.1] [Reference Citation Analysis]
374 Kohler I, Bronsert P, Timme S, Werner M, Brabletz T, Hopt UT, Schilling O, Bausch D, Keck T, Wellner UF. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 2015;30 Suppl 1:78-84. [PMID: 25827809 DOI: 10.1111/jgh.12752] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
375 van de Ven RA, Tenhagen M, Meuleman W, van Riel JJ, Schackmann RC, Derksen PW. Nuclear p120-catenin regulates the anoikis resistance of mouse lobular breast cancer cells through Kaiso-dependent Wnt11 expression. Dis Model Mech 2015;8:373-84. [PMID: 25713299 DOI: 10.1242/dmm.018648] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
376 Christgen M, Derksen P. Lobular breast cancer: molecular basis, mouse and cellular models. Breast Cancer Res 2015;17:16. [PMID: 25757734 DOI: 10.1186/s13058-015-0517-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
377 Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study. Fam Cancer 2014;13:231-42. [PMID: 24389957 DOI: 10.1007/s10689-013-9698-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
378 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223-62; quiz 263. [PMID: 25645574 DOI: 10.1038/ajg.2014.435] [Cited by in Crossref: 957] [Cited by in F6Publishing: 948] [Article Influence: 119.6] [Reference Citation Analysis]
379 Sauer BG, Powell SM. Biology of human stomach cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.026] [Reference Citation Analysis]
380 Current state of the evolving MMMN cancer progression models of cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.022] [Reference Citation Analysis]
381 McCart Reed AE, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics. Breast Cancer Res 2015;17:12. [PMID: 25849106 DOI: 10.1186/s13058-015-0519-x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 193] [Article Influence: 21.8] [Reference Citation Analysis]
382 Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015; 21(1): 112-123 [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
383 Carneiro F, Grabsch HI. Pathogenesis of Gastric Cancer. Minimally Invasive Foregut Surgery for Malignancy 2015. [DOI: 10.1007/978-3-319-09342-0_6] [Reference Citation Analysis]
384 Tang LH, Selby LV. Pathology of Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_4] [Reference Citation Analysis]
385 Pattison S, Boussioutas A. Pathophysiology of Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
386 Poultsides G, Norton JA. Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
387 Mishra J, Ruggiero P, Bagnoli F, Rappuoli R, Stein M. Helicobacter pylori: The Cancer Bug. Infection and Cancer: Bi-Directorial Interactions 2015. [DOI: 10.1007/978-3-319-20669-1_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
388 Reis CA. Gastric Cancer. Encyclopedia of Cancer 2015. [DOI: 10.1007/978-3-642-27841-9_2329-2] [Reference Citation Analysis]
389 Li J, Lin F. Upper Gastrointestinal Tract. Handbook of Practical Immunohistochemistry 2015. [DOI: 10.1007/978-1-4939-1578-1_27] [Reference Citation Analysis]
390 Haverkamp L, van der Sluis PC, Ausems MG, van der Horst S, Siersema PD, Ruurda JP, Offerhaus GJ, van Hillegersberg R. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation. J Gastrointest Surg 2015;19:2120-5. [PMID: 26443527 DOI: 10.1007/s11605-015-2963-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
391 Yi JH, Do IG, Jang J, Kim ST, Kim KM, Park SH, Park JO, Park YS, Lim HY, Kang WK. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer. Sci Rep. 2014;4:7592. [PMID: 25534230 DOI: 10.1038/srep07592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
392 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
393 Sanches JM, Figueiredo J, Fonseca M, Durães C, Melo S, Esménio S, Seruca R. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet 2015;23:1072-9. [PMID: 25388006 DOI: 10.1038/ejhg.2014.240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
394 Bouzoubaa W, Laadioui M, Alaoui FZ, Jayi S, Bouguern H, Chaara H, Melhouf MA. [The place of magnetic resonance imaging in lobular carcinoma of the breast]. Pan Afr Med J 2014;18:21. [PMID: 25368710 DOI: 10.11604/pamj.2014.18.21.4055] [Reference Citation Analysis]
395 Gaston D, Hansford S, Oliveira C, Nightingale M, Pinheiro H, Macgillivray C, Kaurah P, Rideout AL, Steele P, Soares G, Huang WY, Whitehouse S, Blowers S, LeBlanc MA, Jiang H, Greer W, Samuels ME, Orr A, Fernandez CV, Majewski J, Ludman M, Dyack S, Penney LS, McMaster CR, Huntsman D, Bedard K. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014;10:e1004669. [PMID: 25340522 DOI: 10.1371/journal.pgen.1004669] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
396 Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V. E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 2014;33:1081-94. [DOI: 10.1007/s10555-014-9528-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
397 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
398 Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA. Medical management of gastric cancer: A 2014 update. World J Gastroenterol 2014; 20(38): 13637-13647 [PMID: 25320502 DOI: 10.3748/wjg.v20.i38.13637] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
399 Zhang L, Xiao A, Ruggeri J, Bacares R, Somar J, Melo S, Figueiredo J, Simões-Correia J, Seruca R, Shah MA. The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutat Res 2014;770:106-11. [PMID: 25771876 DOI: 10.1016/j.mrfmmm.2014.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
400 Cancer of the oesophagus and stomach. Cancer and its Management 2014. [DOI: 10.1002/9781118468753.ch14] [Reference Citation Analysis]
401 Rainville IR, Rana HQ. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity. Curr Oncol Rep. 2014;16:371. [PMID: 24488544 DOI: 10.1007/s11912-013-0371-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
402 Zhou J, Hayakawa Y, Wang Timothy C, Bass Adam J. RhoA Mutations Identified in Diffuse Gastric Cancer. Cancer Cell. 2014;26:9-11. [PMID: 25026207 DOI: 10.1016/j.ccr.2014.06.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
403 Cho M, Eze O, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet 2014; 4(3): 58-68 [DOI: 10.5496/wjmg.v4.i3.58] [Reference Citation Analysis]
404 Koelzer VH, Langer R, Zlobec I, Lugli A. Tumor budding in upper gastrointestinal carcinomas. Front Oncol 2014;4:216. [PMID: 25177546 DOI: 10.3389/fonc.2014.00216] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
405 Moreira-Nunes CA, Barros MBL, do Nascimento Borges B, Montenegro RC, Lamarão LM, Ribeiro HF, Bona AB, Assumpção PP, Rey JA, Pinto GR, Burbano RR. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hered Cancer Clin Pract 2014;12:18. [PMID: 25180051 DOI: 10.1186/1897-4287-12-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
406 Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308. [PMID: 25184143 DOI: 10.1155/2014/637308] [Cited by in Crossref: 63] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
407 Waldum HL, Ringnes E, Nordbø H, Sørdal Ø, Nordrum IS, Hauso Ø. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin. Scand J Gastroenterol 2014;49:974-8. [PMID: 24742175 DOI: 10.3109/00365521.2014.909275] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
408 Chen A, Beetham H, Black MA, Priya R, Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS, Guilford PJ. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer 2014;14:552. [PMID: 25079037 DOI: 10.1186/1471-2407-14-552] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
409 Chen A, Beetham H, Black MA, Priya R, Telford BJ, Guest J, Wiggins GA, Godwin TD, Yap AS, Guilford PJ. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer 2014;14:552. [PMID: 25079037 DOI: 10.1186/1471-2407-14-552] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 9.1] [Reference Citation Analysis]
410 Augustine Chen, Henry Beetham, Michael A Black, Rashmi Priya, Bryony J Telford, Joanne Guest, George A R Wiggins, Tanis D Godwin, Alpha S Yap, Parry J Guilford. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition. BMC Cancer 2014;14:552. [PMID: 25079037 DOI: 10.1186/1471-2407-14-552] [Cited by in Crossref: 88] [Article Influence: 9.8] [Reference Citation Analysis]
411 Lee DG, Kim HS, Lee YS, Kim S, Cha SY, Ota I, Kim NH, Cha YH, Yang DH, Lee Y. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. Nat Commun. 2014;5:4423. [PMID: 25055241 DOI: 10.1038/ncomms5423] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
412 Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: A summary from 10th IGCC. World J Gastroenterol 2014; 20(27): 8986-8992 [PMID: 25083072 DOI: 10.3748/wjg.v20.i27.8986] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
413 Kaneda A, Matsusaka K, Sakai E, Funata S. DNA methylation accumulation and its predetermination of future cancer phenotypes. J Biochem 2014;156:63-72. [PMID: 24962701 DOI: 10.1093/jb/mvu038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
414 Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. Int J Cancer. 2014;135:1756-1763. [PMID: 24945890 DOI: 10.1002/ijc.28988] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
415 Minami Y, Kawai M, Fujiya T, Suzuki M, Noguchi T, Yamanami H, Kakugawa Y, Nishino Y. Family history, body mass index and survival in Japanese patients with stomach cancer: a prospective study. Int J Cancer 2015;136:411-24. [PMID: 24890283 DOI: 10.1002/ijc.29001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
416 Carneiro F, Wen X, Seruca R, Oliveira C. Familial gastric carcinoma. Diagnostic Histopathology 2014;20:239-46. [DOI: 10.1016/j.mpdhp.2014.03.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
417 Lopasso FP. GASTRIC CANCER. A FLEETING GLIMPSE AT ITS GENETIC EVIDENCES. Arq Gastroenterol 2014;51:77-78. [DOI: 10.1590/s0004-28032014000200001] [Reference Citation Analysis]
418 Kim S, Chung JW, Jeong TD, Park YS, Lee JH, Ahn JY, Kim DH, Choi KD, Lee W, Song HJ, Lee GH, Chun S, Jung HY, Min WK, Kim JH. Searching for E-cadherin gene mutations in early onset diffuse gastric cancer and hereditary diffuse gastric cancer in Korean patients. Fam Cancer 2013;12:503-7. [PMID: 23264079 DOI: 10.1007/s10689-012-9595-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
419 Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, Ichimura T, Ushiku T, Funahashi S, Tateishi K, Wada I, Shimizu N, Nomura S, Koike K, Seto Y, Fukayama M, Aburatani H, Ishikawa S. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 2014;46:583-587. [PMID: 24816255 DOI: 10.1038/ng.2984] [Cited by in Crossref: 354] [Cited by in F6Publishing: 372] [Article Influence: 39.3] [Reference Citation Analysis]
420 Alrazzak MA, Zablahalabi J, Alrazzak B, De Angulo G. A concurrent episode of two neoplasms in a toddler-age child. Avicenna J Med 2014;4:48-50. [PMID: 24761385 DOI: 10.4103/2231-0770.130347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
421 King TA, Reis-Filho JS. Lobular neoplasia. Surg Oncol Clin N Am 2014;23:487-503. [PMID: 24882347 DOI: 10.1016/j.soc.2014.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
422 Matsusaka K, Funata S, Fukayama M, Kaneda A. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. World J Gastroenterol 2014; 20(14): 3916-3926 [PMID: 24744581 DOI: 10.3748/wjg.v20.i14.3916] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
423 Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Dig Dis 2014;32:249-64. [PMID: 24732191 DOI: 10.1159/000357858] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
424 Lubkov V, Bar-Sagi D. E-cadherin-mediated cell coupling is required for apoptotic cell extrusion. Curr Biol 2014;24:868-74. [PMID: 24704076 DOI: 10.1016/j.cub.2014.02.057] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
425 Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P, Van Cutsem E, van de Velde C, Cervantes A. Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev. 2014;40:692-700. [PMID: 24656602 DOI: 10.1016/j.ctrv.2014.03.002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 14.0] [Reference Citation Analysis]
426 Horvath A, Pakala SB, Mudvari P, Reddy SD, Ohshiro K, Casimiro S, Pires R, Fuqua SA, Toi M, Costa L, Nair SS, Sukumar S, Kumar R. Novel insights into breast cancer genetic variance through RNA sequencing. Sci Rep 2013;3:2256. [PMID: 23884293 DOI: 10.1038/srep02256] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
427 Li J, McBean E, Li X, Berho M, Szomstein S, Rosenthal RJ. Laparoscopic prophylactic total gastrectomy with linear stapler side-to-side esophagojejunal anastomosis for hereditary diffuse gastric cancer syndrome in 2 siblings. Surg Laparosc Endosc Percutan Tech. 2013;23:e124-e126. [PMID: 23752020 DOI: 10.1097/SLE.0b013e3182773e38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
428 Yoda Y, Takeshima H, Niwa T, Kim JG, Ando T, Kushima R, Sugiyama T, Katai H, Noshiro H, Ushijima T. Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 2015;18:65-76. [DOI: 10.1007/s10120-014-0348-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 8.2] [Reference Citation Analysis]
429 Molinaro V, Pensotti V, Marabelli M, Feroce I, Barile M, Pozzi S, Laghi L, Serrano D, Bernard L, Bonanni B, Ranzani GN. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome. Genes Chromosomes Cancer 2014;53:432-45. [PMID: 24493355 DOI: 10.1002/gcc.22155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
430 Bordeira-Carriço R, Ferreira D, Mateus DD, Pinheiro H, Pêgo AP, Santos MA, Oliveira C. Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. Eur J Hum Genet 2014;22:1085-92. [PMID: 24424122 DOI: 10.1038/ejhg.2013.292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
431 Zoras O, Katsios CS, Roukos DH. Personalizing prophylactic surgery in cancer: current practice and future perspectives from new genome-wide association studies. Expert Review of Anticancer Therapy 2014;11:813-6. [DOI: 10.1586/era.11.22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
432 Senol K, Ozkan MB, Vural S, Tez M. The role of inflammation in gastric cancer. Adv Exp Med Biol 2014;816:235-57. [PMID: 24818726 DOI: 10.1007/978-3-0348-0837-8_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
433 Müller K, Wagner E. RNAi-Based Nano-Oncologicals: Delivery and Clinical Applications. Nano-Oncologicals 2014. [DOI: 10.1007/978-3-319-08084-0_9] [Reference Citation Analysis]
434 Lauwers GY, Mullen JT, Chelcun Schreiber KE, Chung DC. Familial Gastric Cancers. Pathology Case Reviews 2014;19:66-73. [DOI: 10.1097/pcr.0000000000000030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
435 Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut 2014;63:64-71. [PMID: 24153248 DOI: 10.1136/gutjnl-2013-305033] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 8.2] [Reference Citation Analysis]
436 Schrader KA, Sharaf R, Alanee S, Offit K. Genetic Factors. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00012-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
437 Fearon ER. Genetic and Epigenetic Alterations in Cancer. Abeloff's Clinical Oncology 2014. [DOI: 10.1016/b978-1-4557-2865-7.00013-8] [Reference Citation Analysis]
438 Shackelford RE, Abdelbaqi MQ, Almhanna K, Meredith K, Coppola D. Molecular Pathology and Diagnostics in Esophago-gastric Cancer. Molecular Pathology and Diagnostics of Cancer 2014. [DOI: 10.1007/978-94-007-7192-5_6] [Reference Citation Analysis]
439 Grin A, Jothy S. Molecular Pathology of Gastrointestinal Tumors. Molecular Testing in Cancer 2014. [DOI: 10.1007/978-1-4899-8050-2_12] [Reference Citation Analysis]
440 Hodgson SV, Foulkes WD, Eng C, Maher ER. Gastrointestinal System. A Practical Guide to Human Cancer Genetics 2014. [DOI: 10.1007/978-1-4471-2375-0_5] [Reference Citation Analysis]
441 Carneiro F. Gastric Cancer. Pathobiology of Human Disease 2014. [DOI: 10.1016/b978-0-12-386456-7.03808-9] [Reference Citation Analysis]
442 Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ. Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer. 2014;110:1053-1057. [PMID: 24366306 DOI: 10.1038/bjc.2013.792] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
443 Ito Y, Yeoh KG. Gastric cancer. Molecular Oncology 2013. [DOI: 10.1017/cbo9781139046947.046] [Reference Citation Analysis]
444 Simões-Correia J, Silva DI, Melo S, Figueiredo J, Caldeira J, Pinto MT, Girão H, Pereira P, Seruca R. DNAJB4 molecular chaperone distinguishes WT from mutant E-cadherin, determining their fate in vitro and in vivo. Hum Mol Genet 2014;23:2094-105. [PMID: 24293545 DOI: 10.1093/hmg/ddt602] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
445 Yun SM, Yoon K, Lee S, Kim E, Kong S, Choe J, Kang JM, Han T, Kim P, Choi Y, Jho S, Yoo H, Bhak J, Yang H, Kim S. PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling. Oncogene 2014;33:5341-7. [DOI: 10.1038/onc.2013.472] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
446 Kandel C, Leclair F, Bou-Hanna C, Laboisse CL, Mosnier JF. Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas. J Clin Pathol 2014;67:307-12. [PMID: 24218028 DOI: 10.1136/jclinpath-2013-201726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
447 Pinho SS, Carvalho S, Marcos-pinto R, Magalhães A, Oliveira C, Gu J, Dinis-ribeiro M, Carneiro F, Seruca R, Reis CA. Gastric cancer: adding glycosylation to the equation. Trends in Molecular Medicine 2013;19:664-76. [DOI: 10.1016/j.molmed.2013.07.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
448 Bellizzi AM. Contributions of molecular analysis to the diagnosis and treatment of gastrointestinal neoplasms. Seminars in Diagnostic Pathology 2013;30:329-61. [DOI: 10.1053/j.semdp.2013.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
449 Garziera M, Canzonieri V, Cannizzaro R, Geremia S, Caggiari L, De Zorzi M, Maiero S, Orzes E, Perin T, Zanussi S, De Paoli P, De Re V. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 2013;8:e77035. [PMID: 24204729 DOI: 10.1371/journal.pone.0077035] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
450 Zhuang MK, Chen FL. Biomarkers of epithelial-mesenchymal transition in gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3204-3210 [DOI: 10.11569/wcjd.v21.i30.3204] [Reference Citation Analysis]
451 McVeigh TP, Choi JK, Miller NM, Green AJ, Kerin MJ. Lobular breast cancer in a CDH1 splice site mutation carrier: case report and review of the literature. Clin Breast Cancer 2014;14:e47-51. [PMID: 24333020 DOI: 10.1016/j.clbc.2013.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
452 Stein M, Ruggiero P, Rappuoli R, Bagnoli F. Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine. Front Immunol. 2013;4:328. [PMID: 24133496 DOI: 10.3389/fimmu.2013.00328] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
453 Goldenring JR. A central role for vesicle trafficking in epithelial neoplasia: intracellular highways to carcinogenesis. Nat Rev Cancer 2013;13:813-20. [PMID: 24108097 DOI: 10.1038/nrc3601] [Cited by in Crossref: 114] [Cited by in F6Publishing: 117] [Article Influence: 11.4] [Reference Citation Analysis]
454 Jeon C, Chang SC, Mu L, Zhao J, Rao JY, Lu QY, Zhang ZF. Genetic variants of peroxisome proliferator-activated receptor δ are associated with gastric cancer. Dig Dis Sci 2013;58:2881-6. [PMID: 23907334 DOI: 10.1007/s10620-013-2770-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
455 Freire P, Figueiredo P, Cardoso R, Donato MM, Sá A, Portela F, Romãozinho JM, Sofia C. Card15 mutations and gastric cancer in a Portuguese population. Scand J Gastroenterol 2013;48:1188-97. [PMID: 24047397 DOI: 10.3109/00365521.2013.832370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
456 Cho JY. Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer. 2013;13:129-135. [PMID: 24156032 DOI: 10.5230/jgc.2013.13.3.129] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
457 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc.2013.170] [Cited by in Crossref: 279] [Cited by in F6Publishing: 307] [Article Influence: 27.9] [Reference Citation Analysis]
458 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
459 Yamada M, Fukagawa T, Nakajima T, Asada K, Sekine S, Yamashita S, Okochi-Takada E, Taniguchi H, Kushima R, Oda I, Saito Y, Ushijima T, Katai H. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. Gastric Cancer. 2014;17:750-756. [PMID: 24037103 DOI: 10.1007/s10120-013-0298-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
460 Hilbers FS, Vreeswijk MP, van Asperen CJ, Devilee P. The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation? Clin Genet 2013;84:407-14. [PMID: 24025038 DOI: 10.1111/cge.12256] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
461 Ghoussaini M, Pharoah PDP, Easton DF. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol. 2013;183:1038-1051. [PMID: 23973388 DOI: 10.1016/j.ajpath.2013.07.003] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 6.7] [Reference Citation Analysis]
462 Vlug E, Ercan C, van der Wall E, van Diest PJ, Derksen PWB. Lobular Breast Cancer: Pathology, Biology, and Options for Clinical Intervention. Arch Immunol Ther Exp 2014;62:7-21. [DOI: 10.1007/s00005-013-0251-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
463 Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 2013;17:1187-201. [PMID: 23957294 DOI: 10.1517/14728222.2013.827174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
464 Sheh A, Fox JG. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4:505-531. [PMID: 23962822 DOI: 10.4161/gmic.26205] [Cited by in Crossref: 124] [Cited by in F6Publishing: 133] [Article Influence: 12.4] [Reference Citation Analysis]
465 Gall TM, Frampton AE. Gene of the month: E-cadherin (CDH1). J Clin Pathol 2013;66:928-32. [PMID: 23940132 DOI: 10.1136/jclinpath-2013-201768] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
466 Evans DG, Ingham SL. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl Clin Genet 2013;6:53-61. [PMID: 23935382 DOI: 10.2147/TACG.S35605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
467 Ha NH, Hunter KW. Using a systems biology approach to understand and study the mechanisms of metastasis. Wiley Interdiscip Rev Syst Biol Med 2014;6:107-14. [PMID: 23873855 DOI: 10.1002/wsbm.1237] [Reference Citation Analysis]
468 Hamilton LE, Jones K, Church N, Medlicott S. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature. BMC Gastroenterol. 2013;13:114. [PMID: 23849133 DOI: 10.1186/1471-230x-13-114] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
469 Wang LY, Liu YP, Chen LG, Chen YL, Tan L, Liu JJ, Jazag A, Ren JL, Guleng B. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells. PLoS One. 2013;8:e67542. [PMID: 23840737 DOI: 10.1371/journal.pone.0067542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
470 Carneiro F. Hereditary gastric cancer. Pathologe. 2012;33 Suppl 2:231-234. [PMID: 23052347 DOI: 10.1007/s00292-012-1677-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
471 Uppal DS, Powell SM. Genetics/genomics/proteomics of gastric adenocarcinoma. Gastroenterol Clin North Am 2013;42:241-60. [PMID: 23639639 DOI: 10.1016/j.gtc.2013.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
472 de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013;42:219-40. [PMID: 23639638 DOI: 10.1016/j.gtc.2013.01.003] [Cited by in Crossref: 253] [Cited by in F6Publishing: 254] [Article Influence: 25.3] [Reference Citation Analysis]
473 Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013;42:261-84. [PMID: 23639640 DOI: 10.1016/j.gtc.2013.01.004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 9.6] [Reference Citation Analysis]
474 Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Noguès C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-puig P, Molière D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 2013;50:486-9. [DOI: 10.1136/jmedgenet-2012-101472] [Cited by in Crossref: 108] [Cited by in F6Publishing: 113] [Article Influence: 10.8] [Reference Citation Analysis]
475 Montgomery M, Fukuhara S, Karpeh M, Brower S. Evidence-based review of the management of early gastric cancer. Gastroenterol Rep (Oxf) 2013;1:105-12. [PMID: 24759815 DOI: 10.1093/gastro/got016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
476 Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, de Jong D, van Krieken JH, van Hillegersberg R, Ligtenberg M, Bleiker E, Cats A; Dutch Working Group on Hereditary Gastric Cancer. Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer. 2012;11:363-369. [PMID: 22388873 DOI: 10.1007/s10689-012-9521-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
477 Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland I. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621-629. [PMID: 23208944 DOI: 10.1002/path.4152] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
478 Ku CS, Cooper DN, Roukos DH. Clinical relevance of cancer genome sequencing. World J Gastroenterol 2013; 19(13): 2011-2018 [PMID: 23599619 DOI: 10.3748/wjg.v19.i13.2011] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
479 Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126:393-401. [PMID: 23525005 DOI: 10.1242/jcs.100115] [Cited by in Crossref: 415] [Cited by in F6Publishing: 451] [Article Influence: 41.5] [Reference Citation Analysis]
480 Chang JT, Mani SA. Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition. Cancer Lett 2013;341:16-23. [PMID: 23499890 DOI: 10.1016/j.canlet.2013.03.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
481 Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013;13:246-57. [PMID: 23467301 DOI: 10.1038/nrc3458] [Cited by in Crossref: 1175] [Cited by in F6Publishing: 1240] [Article Influence: 117.5] [Reference Citation Analysis]
482 Fang WL, Chang SC, Lan YT, Huang KH, Lo SS, Li AF, Chi CW, Wu CW, Chiou SH. Molecular and survival differences between familial and sporadic gastric cancers. Biomed Res Int 2013;2013:396272. [PMID: 23555086 DOI: 10.1155/2013/396272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
483 Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012;18:355-363. [PMID: 22846738 DOI: 10.1097/ppo.0b013e31826246dc] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
484 Hayakawa Y, Fox JG, Gonda T, Worthley DL, Muthupalani S, Wang TC. Mouse models of gastric cancer. Cancers (Basel). 2013;5:92-130. [PMID: 24216700 DOI: 10.3390/cancers5010092] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
485 Nadauld LD, Ford JM. Molecular profiling of gastric cancer: toward personalized cancer medicine. J Clin Oncol. 2013;31:838-839. [PMID: 23341521 DOI: 10.1200/jco.2012.47.1714] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
486 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
487 Wong H, Yau T. Molecular targeted therapies in advanced gastric cancer: does tumor histology matter? Therap Adv Gastroenterol. 2013;6:15-31. [PMID: 23320047 DOI: 10.1177/1756283x12453636] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
488 Brett A, Pandey S, Fraizer G. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells. Mol Cancer 2013;12:3. [PMID: 23298185 DOI: 10.1186/1476-4598-12-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
489 Rhim AD, Sohal D, Nakagawa H. Molecular Mechanisms of Tumor Metastasis. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_13] [Reference Citation Analysis]
490 Corso G, Velho S. Gastric Cancer in Other Inherited Syndromes. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_15] [Reference Citation Analysis]
491 Boland CR, Jung B, Carethers JM. Cancer of the Colon and Gastrointestinal Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00074-4] [Reference Citation Analysis]
492 Tannapfel A. Karzinom des Magens. Pathologie 2013. [DOI: 10.1007/978-3-642-02322-4_12] [Reference Citation Analysis]
493 Carvalho J, Pinheiro H, Oliveira C. E-Cadherin Germline Mutations. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
494 Ha N, Faraji F, Hunter KW. Mechanisms of Metastasis. Cancer Targeted Drug Delivery 2013. [DOI: 10.1007/978-1-4614-7876-8_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
495 Miller ME, Nielsen SM, Kulkarni SA. Management of Concomitant Risk. Management of the Patient at High Risk for Breast Cancer 2013. [DOI: 10.1007/978-1-4614-5891-3_10] [Reference Citation Analysis]
496 Elston MS. Pituitary Adenomas: Role of E-Cadherin in Tumor Invasion. Tumors of the Central Nervous System, Volume 10 2013. [DOI: 10.1007/978-94-007-5681-6_19] [Reference Citation Analysis]
497 Keller G. Hereditary Diffuse Gastric Cancer and Lobular Breast Carcinoma. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_11] [Reference Citation Analysis]
498 Wei Q, Huang H. Insights into the role of cell-cell junctions in physiology and disease. Int Rev Cell Mol Biol 2013;306:187-221. [PMID: 24016526 DOI: 10.1016/B978-0-12-407694-5.00005-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
499 Figueiredo J, Seruca R. Germline Missense Mutants in Hereditary Diffuse Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
500 Gaudet MM, Brooks JD, Robson ME, Bernstein JL. Genetic Epidemiology of Breast Cancer. Women and Health 2013. [DOI: 10.1016/b978-0-12-384978-6.00073-x] [Reference Citation Analysis]
501 Corso G, Marrelli D, Roviello F. Clinical Management of Familial Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
502 Corso G. Historical Overview of Familial Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_1] [Reference Citation Analysis]
503 Silva EMD, Fregnani JHTG, Martel G, Costa Jr. WL, Coimbra FJF, Achatz MIW, Hainaut P, Soares FA. Molecular Analyses of Early-Onset Gastric Cancer in Brazilian Patients: <i>TP</i>53 Mutations, Cadherin-Catenin and Mucins Proteins Expression. JCT 2013;04:33-42. [DOI: 10.4236/jct.2013.41a005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
504 Odegaard JI, Schrijver I. Molecular Pathology of Hereditary Diffuse Gastric Cancer. JCT 2013;04:554-561. [DOI: 10.4236/jct.2013.42070] [Reference Citation Analysis]
505 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
506 Carneiro F. Pathology of Hereditary Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
507 Hansford S, Huntsman D. Beyond CDH1 Mutations: Causes of Hereditary Diffuse Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_9] [Reference Citation Analysis]
508 De Falco G, Videtta AD. Clinical Criteria for Familial Gastric Cancer Definition. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_13] [Reference Citation Analysis]
509 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013;116:337-59. [PMID: 23481202 DOI: 10.1016/B978-0-12-394311-8.00015-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
510 Das K, Tan P. Using Genomic Biomarkers to Predict Patient Prognosis and Treatment Response in Gastric Cancer. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine 2013. [DOI: 10.1007/978-1-62703-456-2_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
511 Gordon OK. Cancer of the Breast and Female Reproductive Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00093-8] [Reference Citation Analysis]
512 Leite M, Corso G, Sousa S, Carvalho J, Roviello F, Oliveira C, Figueiredo C, Seruca R. Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_10] [Reference Citation Analysis]
513 Corso G, Roncalli F, Marrelli D, Carneiro F, Roviello F. History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family. Biomed Res Int 2013;2013:385132. [PMID: 23484115 DOI: 10.1155/2013/385132] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
514 Blair V, Kahokehr A, Sammour T. Cancer in Māori: lessons from prostate, colorectal and gastric cancer and progress in hereditary stomach cancer in New Zealand: Prostate, colon and gastric cancer in Māori. ANZ J Surg 2013;83:42-8. [DOI: 10.1111/ans.12042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
515 Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JHJ, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract 2012;10:18. [PMID: 23231819 DOI: 10.1186/1897-4287-10-18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
516 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
517 Yantiss RK, Samowitz WS. Molecular Pathology of Gastrointestinal Cancer. Surg Pathol Clin 2012;5:821-42. [PMID: 26838505 DOI: 10.1016/j.path.2012.08.002] [Reference Citation Analysis]
518 Vogelaar IP, Figueiredo J, van Rooij IA, Simões-Correia J, van der Post RS, Melo S, Seruca R, Carels CE, Ligtenberg MJ, Hoogerbrugge N. Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. Hum Mol Genet 2013;22:919-26. [PMID: 23197654 DOI: 10.1093/hmg/dds497] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
519 Lu J, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, Lin JX. Analysis on the clinical and pathological features and prognosis of familial gastric cancer in South china population: a single-center study of 724 patients. J Oncol 2012;2012:641218. [PMID: 23209465 DOI: 10.1155/2012/641218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
520 Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107:230-236. [PMID: 23129495 DOI: 10.1002/jso.23262] [Cited by in Crossref: 296] [Cited by in F6Publishing: 330] [Article Influence: 26.9] [Reference Citation Analysis]
521 Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012;11:4323-7. [PMID: 23085543 DOI: 10.4161/cc.22388] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
522 Chaturvedi A, Hoffman LM, Welm AL, Lessnick SL, Beckerle MC. The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma. Genes Cancer 2012;3:102-16. [PMID: 23050043 DOI: 10.1177/1947601912457024] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 5.7] [Reference Citation Analysis]
523 Gomceli I, Demiriz B, Tez M. Gastric carcinogenesis. World J Gastroenterol 2012; 18(37): 5164-5170 [PMID: 23066309 DOI: 10.3748/wjg.v18.i37.5164] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
524 Janjigian YY, Kelsen DP. Genomic Dysregulation in gastric tumors: Genomic Dysregulation in Gastric Tumors. J Surg Oncol 2013;107:237-42. [DOI: 10.1002/jso.23263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
525 Tupara H. Ethics and Health Research: Decision Making in Aotearoa New Zealand. AJOB Primary Research 2012;3:40-52. [DOI: 10.1080/21507716.2012.714834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
526 van Horssen R, Hollestelle A, Rens JAP, Eggermont AMM, Schutte M, ten Hagen TLM. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 2012;136:365-77. [DOI: 10.1007/s10549-012-2261-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
527 Giordano A, Cito L. Advances in gastric cancer prevention. World J Clin Oncol 2012; 3(9): 128-136 [PMID: 23061031 DOI: 10.5306/wjco.v3.i9.128] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
528 Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal malignancies. World J Gastroenterol 2012; 18(33): 4507-4516 [PMID: 22969223 DOI: 10.3748/wjg.v18.i33.4507] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
529 Dixon M, Seevaratnam R, Wirtzfeld D, Mcleod R, Helyer L, Law C, Swallow C, Paszat L, Bocicariu A, Cardoso R, Mahar A, Bekaii-saab T, Chau I, Church N, Coit D, Crane CH, Earle C, Mansfield P, Marcon N, Miner T, Noh SH, Porter G, Posner MC, Prachand V, Sano T, Van de Velde CJH, Wong S, Coburn N. A RAND/UCLA Appropriateness Study of the Management of Familial Gastric Cancer. Ann Surg Oncol 2013;20:533-41. [DOI: 10.1245/s10434-012-2584-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
530 Ding J, Zhang Z, Pan Y, Liao G, Zeng L, Chen S. Expression and significance of twist, E-cadherin, and N-cadherin in gastrointestinal stromal tumors. Dig Dis Sci 2012;57:2318-24. [PMID: 22576709 DOI: 10.1007/s10620-012-2186-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
531 Yang D, Hendifar A, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz HJ. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2:77-84. [PMID: 22811834 DOI: 10.3978/j.issn.2078-6891.2010.025] [Cited by in F6Publishing: 83] [Reference Citation Analysis]
532 Becker SF, Langhe R, Huang C, Wedlich D, Kashef J. Giving the right tug for migration: Cadherins in tissue movements. Archives of Biochemistry and Biophysics 2012;524:30-42. [DOI: 10.1016/j.abb.2012.02.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
533 Figueiredo J, Söderberg O, Simões-Correia J, Grannas K, Suriano G, Seruca R. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 2013;21:301-9. [PMID: 22850631 DOI: 10.1038/ejhg.2012.159] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 5.0] [Reference Citation Analysis]
534 Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
535 de Cuba EMV, Kwakman R, van Egmond M, Bosch LJW, Bonjer HJ, Meijer GA, te Velde EA. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012;461:231-43. [DOI: 10.1007/s00428-012-1287-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
536 Pinheiro H, Carvalho J, Oliveira P, Ferreira D, Pinto MT, Osório H, Licastro D, Bordeira-Carriço R, Jordan P, Lazarevic D. Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesis. Hum Mol Genet. 2012;21:4253-4269. [PMID: 22752307 DOI: 10.1093/hmg/dds248] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
537 Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol Biol. 2012;863:411-435. [PMID: 22359309 DOI: 10.1007/978-1-61779-612-8_26] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 8.1] [Reference Citation Analysis]
538 Zabaleta J. Multifactorial etiology of gastric cancer. Methods Mol Biol. 2012;863:411-435. [PMID: 22359309 DOI: 10.1007/978-1-61779-612-8_26.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
539 Shah MA. Will Disease Heterogeneity Help Define Treatment Paradigms for Gastroesophageal Adenocarcinoma? A Global Perspective. American Society of Clinical Oncology Educational Book 2012. [DOI: 10.14694/edbook_am.2012.32.142] [Reference Citation Analysis]
540 Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228:31-44. [PMID: 22450781 DOI: 10.1002/path.4032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 84] [Article Influence: 3.0] [Reference Citation Analysis]
541 Shin WG, Kim HJ, Cho SJ, Kim HS, Kim KH, Jang MK, Lee JH, Kim HY. The COX-2-1195AA Genotype Is Associated with Diffuse-Type Gastric Cancer in Korea. Gut Liver. 2012;6:321-327. [PMID: 22844559 DOI: 10.5009/gnl.2012.6.3.321] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
542 Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Sim窄es-Correia J, Oliveira MJ. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826:297-311. [PMID: 22613680 DOI: 10.1016/j.bbcan.2012.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 101] [Article Influence: 4.0] [Reference Citation Analysis]
543 He H, Chen W, Wang X, Wang C, Liu F, Shen Z, Xu J, Gu J, Sun Y. Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. Cancer Sci. 2012;103:1296-1303. [PMID: 22471696 DOI: 10.1111/j.1349-7006.2012.02295.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
544 Dai YH, Tang YP, Zhu HY, Lv L, Chu Y, Zhou YQ, Huo JR. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dig Dis Sci 2012;57:1253-60. [PMID: 22350782 DOI: 10.1007/s10620-012-2042-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
545 Garziera M, De Re V, Geremia S, Seruca R, Figueiredo J, Melo S, Simões-Correia J, Caggiari L, De Zorzi M, Canzonieri V, Cannizzaro R, Toffoli G. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clin Exp Med 2013;13:149-57. [PMID: 22543498 DOI: 10.1007/s10238-012-0184-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
546 Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011;3:19-34. [PMID: 22126150 DOI: 10.2217/epi.10.64] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
547 Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B. Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol. 2012;25:1055-1068. [PMID: 22522846 DOI: 10.1038/modpathol.2012.62] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
548 Kim T, Youm S, Shin S, Kim DJ, Hong JT, Kim Y, Nam S, Ahn B. Chemopreventive effects of elm tree bark extract on Helicobacter pylori-associated mouse gastric carcinogenesis: Elm tree extract and mouse gastric cancer. Basic and Applied Pathology 2012;5:31-8. [DOI: 10.1111/j.1755-9294.2012.01125.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
549 Wilmanns C, Steinhauer S, Großmann J, Schmitt-gräff A, Ruf G. Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration. Cancer Metastasis Rev 2012;31:269-76. [DOI: 10.1007/s10555-012-9350-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
550 Simões-Correia J, Figueiredo J, Lopes R, Stricher F, Oliveira C, Serrano L, Seruca R. E-cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer. PLoS One 2012;7:e33783. [PMID: 22470475 DOI: 10.1371/journal.pone.0033783] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
551 Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol. 2012;47:351-358. [PMID: 22402775 DOI: 10.1007/s00535-012-0565-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
552 Blair VR. Familial gastric cancer: genetics, diagnosis, and management. Surg Oncol Clin N Am 2012;21:35-56. [PMID: 22098830 DOI: 10.1016/j.soc.2011.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
553 Rao Q, Wang JY, Meng J, Tang K, Wang Y, Wang M, Xing H, Tian Z, Wang J. Low-expression of E-cadherin in leukaemia cells causes loss of homophilic adhesion and promotes cell growth. Cell Biol Int 2011;35:945-51. [PMID: 21143205 DOI: 10.1042/CBI20100456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
554 Choi YL, Soda M, Ueno T, Hamada T, Haruta H, Yamato A, Fukumura K, Ando M, Kawazu M, Yamashita Y, Mano H. Oncogenic MAP2K1 mutations in human epithelial tumors. Carcinogenesis 2012;33:956-61. [PMID: 22327936 DOI: 10.1093/carcin/bgs099] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
555 Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8. [PMID: 22225527 DOI: 10.1186/1471-2407-12-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
556 Takeuchi T, Adachi Y, Nagayama T. A WWOX-binding molecule, transmembrane protein 207, is related to the invasiveness of gastric signet-ring cell carcinoma. Carcinogenesis 2012;33:548-54. [PMID: 22226915 DOI: 10.1093/carcin/bgs001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
557 Sereno M, Aguayo C, Guillén Ponce C, Gómez-Raposo C, Zambrana F, Gómez-López M, Casado E. Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention. Clin Transl Oncol. 2011;13:599-610. [PMID: 21865131 DOI: 10.1007/s12094-011-0705-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
558 Trachtenberg AJ, Robert JH, Abdalla AE, Fraser A, He SY, Lacy JN, Rivas-Morello C, Truong A, Hardiman G, Ohno-Machado L, Liu F, Hovig E, Kuo WP. A primer on the current state of microarray technologies. Methods Mol Biol 2012;802:3-17. [PMID: 22130870 DOI: 10.1007/978-1-61779-400-1_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
559 Ryu CB, Chen YK. Endoscopic Therapy for Gastric Neoplasms. Clinical Gastrointestinal Endoscopy 2012. [DOI: 10.1016/b978-1-4377-1529-3.00033-6] [Reference Citation Analysis]
560 Geyer FC, Reis-filho JS, Dabbs DJ. Lobular Neoplasia and Invasive Lobular Carcinoma. Breast Pathology. Elsevier; 2012. pp. 380-411. [DOI: 10.1016/b978-1-4377-0604-8.00021-7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
561 Corso G, Marrelli D, Roviello F. Etiopathogenesis of Gastric Cancer. Surgery in the Multimodal Management of Gastric Cancer 2012. [DOI: 10.1007/978-88-470-2318-5_2] [Reference Citation Analysis]
562 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease. Elsevier; 2012. pp. 415-41. [DOI: 10.1016/b978-0-12-388415-2.00021-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
563 Vasioukhin V. Adherens junctions and cancer. Subcell Biochem 2012;60:379-414. [PMID: 22674080 DOI: 10.1007/978-94-007-4186-7_16] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
564 Lee A, Park J, Nam M, Bang H, Yang J, Choi K, Kim S, Chung J, Kwack K. Polymorphisms of CDH9 and CDH10 in Chromosome 5p14 Associated with Autism in the Korean Population. Journal of the Korean Academy of Child and Adolescent Psychiatry 2011;22:287-93. [DOI: 10.5765/jkacap.2011.22.4.287] [Reference Citation Analysis]
565 Ahrens T, Stetefeld J, Häussinger D, Engel J. The Superfamily of Cadherins: Calcium-Dependent Cell Adhesion Receptors. Encyclopedia of Inorganic and Bioinorganic Chemistry 2011. [DOI: 10.1002/9781119951438.eibc0525] [Reference Citation Analysis]
566 Masciari S, Dewanwala A, Stoffel EM, Lauwers GY, Zheng H, Achatz MI, Riegert-Johnson D, Foretova L, Silva EM, Digianni L, Verselis SJ, Schneider K, Li FP, Fraumeni J, Garber JE, Syngal S. Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med. 2011;13:651-657. [PMID: 21552135 DOI: 10.1097/gim.0b013e31821628b6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
567 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S153-S163. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
568 Baltogiannis G, Katsios CS, Roukos DH. Targeting the individual cancer patient. Advances in personalized cancer management. Unitec House: Future Medicine Ltd; 2011. pp. 8-28. [DOI: 10.2217/ebo.11.279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
569 Park JH, Park J, Choi JK, Lyu J, Bae MG, Lee YG, Bae JB, Park DY, Yang HK, Kim TY, Kim YJ. Identification of DNA methylation changes associated with human gastric cancer. BMC Med Genomics 2011;4:82. [PMID: 22133303 DOI: 10.1186/1755-8794-4-82] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
570 Sohal DP, Sun W. What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy? Expert Rev Anticancer Ther 2011;11:1843-50. [PMID: 22117152 DOI: 10.1586/era.11.170] [Reference Citation Analysis]
571 Sun C, Chen X, Wang BM. Genetic features of familial gastric cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3318-3322 [DOI: 10.11569/wcjd.v19.i32.3318] [Reference Citation Analysis]
572 Chen Y, Pan K, Li S, Xia J, Wang W, Chen J, Zhao J, Lü L, Wang D, Pan Q. Decreased expression of V-set and immunoglobulin domain containing 1 (VSIG1) is associated with poor prognosis in primary gastric cancer. J Surg Oncol. 2012;106:286-293. [PMID: 22095633 DOI: 10.1002/jso.22150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
573 Boonstra JJ, van Marion R, Douben HJ, Lanchbury JS, Timms KM, Abkevich V, Tilanus HW, de Klein A, Dinjens WN. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts. Genes Chromosomes Cancer 2012;51:272-82. [PMID: 22081516 DOI: 10.1002/gcc.20952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
574 Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics. 2011;12:130-137. [PMID: 21966251 DOI: 10.2174/138920211795564359] [Cited by in Crossref: 133] [Cited by in F6Publishing: 147] [Article Influence: 11.1] [Reference Citation Analysis]
575 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
576 Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, Chan TL, Kan Z, Chan AS, Tsui WY, Lee SP, Ho SL, Chan AK, Cheng GH, Roberts PC, Rejto PA, Gibson NW, Pocalyko DJ, Mao M, Xu J, Leung SY. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011;43:1219-1223. [PMID: 22037554 DOI: 10.1038/ng.982] [Cited by in Crossref: 550] [Cited by in F6Publishing: 589] [Article Influence: 45.8] [Reference Citation Analysis]
577 Kasaian K, Jones SJ. A new frontier in personalized cancer therapy: mapping molecular changes. Future Oncol 2011;7:873-94. [PMID: 21732758 DOI: 10.2217/fon.11.63] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
578 Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N; Dutch Working Group on Hereditary Gastric Cancer. CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 2012;131:367-76. [PMID: 22020549 DOI: 10.1002/ijc.26398] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
579 Ferreira AC, Suriano G, Mendes N, Gomes B, Wen X, Carneiro F, Seruca R, Machado JC. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Human Molecular Genetics 2012;21:334-43. [DOI: 10.1093/hmg/ddr469] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
580 Ottenhof NA, de Wilde RF, Morsink FH, de Leng WW, Ausems MG, Morreau H, van Hillegersberg R, Offerhaus GJ, Milne AN. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Hum Pathol 2012;43:457-61. [PMID: 21992816 DOI: 10.1016/j.humpath.2011.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
581 Corso G, Marrelli D, Roviello F. Familial gastric cancer: update for practice management. Fam Cancer 2011;10:391-6. [PMID: 21184285 DOI: 10.1007/s10689-010-9410-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
582 Svrcek M. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Ann Pathol 2011;31:381-4. [PMID: 21982246 DOI: 10.1016/j.annpat.2011.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
583 Williams CS, Zhang B, Smith JJ, Jayagopal A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO. BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. J Clin Invest. 2011;121:4056-4069. [PMID: 21911938 DOI: 10.1172/jci44228.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
584 Williams CS, Zhang B, Smith JJ, Jayagopal A, Barrett CW, Pino C, Russ P, Presley SH, Peng D, Rosenblatt DO, Haselton FR, Yang JL, Washington MK, Chen X, Eschrich S, Yeatman TJ, El-Rifai W, Beauchamp RD, Chang MS. BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. J Clin Invest 2011;121:4056-69. [PMID: 21911938 DOI: 10.1172/JCI44228] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
585 Toiyama Y, Yasuda H, Saigusa S, Matushita K, Fujikawa H, Tanaka K, Mohri Y, Inoue Y, Goel A, Kusunoki M. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int J Cancer. 2012;130:2912-2921. [PMID: 21796631 DOI: 10.1002/ijc.26330] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
586 Figueiredo J, Simões-Correia J, Söderberg O, Suriano G, Seruca R. ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones. PLoS One 2011;6:e23188. [PMID: 21853084 DOI: 10.1371/journal.pone.0023188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
587 O'Connor PM, Lapointe TK, Jackson S, Beck PL, Jones NL, Buret AG. Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun 2011;79:3887-94. [PMID: 21825064 DOI: 10.1128/IAI.05109-11] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
588 Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet. 2012;82:283-287. [PMID: 21696387 DOI: 10.1111/j.1399-0004.2011.01744.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
589 Tao J, Deng NT, Ramnarayanan K, Huang B, Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J. CD44-SLC1A2 gene fusions in gastric cancer. Sci Transl Med. 2011;3:77ra30. [PMID: 21471434 DOI: 10.1126/scitranslmed.3001423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
590 Lynch HT, Aldoss I, Lynch JF. The identification and management of hereditary diffuse gastric cancer in a large Jordanian family. Familial Cancer 2011;10:667-72. [DOI: 10.1007/s10689-011-9463-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
591 Udhayakumar G, Jayanthi V, Devaraj N, Devaraj H. Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma. Mol Cell Biochem 2011;357:283-93. [PMID: 21678082 DOI: 10.1007/s11010-011-0899-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
592 Micev M, Cosić-Micev M. [Pathology and pathobiology of the gastric carcinoma]. Acta Chir Iugosl 2011;58:39-52. [PMID: 21634103 DOI: 10.2298/aci1101039m] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
593 Yu J, Li Z. The sex ratio and age of onset features of gastric cancer patients in hereditary diffuse gastric cancer families. Familial Cancer 2011;10:573-9. [DOI: 10.1007/s10689-011-9452-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
594 Nakajima TE, Yamada Y. Gastric Cancer Metastasis. Cancer Metastasis 2011. [DOI: 10.1017/cbo9780511976117.032] [Reference Citation Analysis]
595 Kouchi Z, Fujiwara Y, Yamaguchi H, Nakamura Y, Fukami K. Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells. Biochem Biophys Res Commun 2011;408:523-9. [PMID: 21514270 DOI: 10.1016/j.bbrc.2011.04.045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
596 Mimata A, Fukamachi H, Eishi Y, Yuasa Y. Loss of E-cadherin in mouse gastric epithelial cells induces signet ring-like cells, a possible precursor lesion of diffuse gastric cancer. Cancer Sci. 2011;102:942-950. [PMID: 21276134 DOI: 10.1111/j.1349-7006.2011.01890.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
597 Venkatachalam R, Verwiel ET, Kamping EJ, Hoenselaar E, Görgens H, Schackert HK, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N, van Kessel AG, Kuiper RP. Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. Int J Cancer 2011;129:1635-42. [PMID: 21128281 DOI: 10.1002/ijc.25821] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 5.0] [Reference Citation Analysis]
598 Jacobs G, Hellmig S, Huse K, Titz A, Franke A, Kwiatkowski R, Ott S, Kosmahl M, Fischbach W, Lucius R, Klapper W, Fölsch UR, Hampe J, Schreiber S, Rosenstiel P. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma. Haematologica 2011;96:987-95. [PMID: 21459793 DOI: 10.3324/haematol.2010.033126] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
599 Katsios C, Roukos DH. Missing heritability, next-generation genome-wide association studies and primary cancer prevention: an Atlantean illusion? Future Oncology 2011;7:477-80. [DOI: 10.2217/fon.11.29] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
600 Thériault C, Pinard M, Comamala M, Migneault M, Beaudin J, Matte I, Boivin M, Piché A, Rancourt C. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol Oncol. 2011;121:434-443. [PMID: 21421261 DOI: 10.1016/j.ygyno.2011.02.020] [Cited by in Crossref: 112] [Cited by in F6Publishing: 120] [Article Influence: 9.3] [Reference Citation Analysis]
601 Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A, Norton JA. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011;18:2594-2598. [PMID: 21424370 DOI: 10.1245/s10434-011-1648-9] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
602 da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Fam Cancer. 2010;9:563-570. [PMID: 20697958 DOI: 10.1007/s10689-010-9373-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
603 Jakubowska A, Lawniczak M, Wojnarska B, Cybulski C, Huzarski T, Byrski T, Tołoczko-Grabarek A, Jaworska K, Durda K, Starzyńska T, Lubiński J. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. Fam Cancer 2010;9:605-8. [PMID: 20842455 DOI: 10.1007/s10689-010-9381-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
604 Ye YW, Dong RZ, Zhou Y, Du CY, Wang CM, Fu H, Shi YQ. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol 2011;104:76-82. [PMID: 21400534 DOI: 10.1002/jso.21896] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
605 Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res 2011;13:R20. [PMID: 21356067 DOI: 10.1186/bcr2832] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 6.9] [Reference Citation Analysis]
606 Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am 2010;24:853-69, vii. [PMID: 20937454 DOI: 10.1016/j.idc.2010.07.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
607 Chang EH, Pezzulo AA, Zabner J. Do cell junction protein mutations cause an airway phenotype in mice or humans? Am J Respir Cell Mol Biol 2011;45:202-20. [PMID: 21297078 DOI: 10.1165/rcmb.2010-0498TR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
608 Milne AN, Offerhaus GJA, Carneiro F. Histopathology of familial and early-onset gastric cancer. Diagnostic Histopathology 2011;17:62-8. [DOI: 10.1016/j.mpdhp.2010.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
609 Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, Shinomura Y. Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 2011;83:241-9. [PMID: 21273772 DOI: 10.1159/000320453] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
610 Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer. 2011;117:3112-3117. [PMID: 21271559 DOI: 10.1002/cncr.25876] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
611 Shah MA, Kurtz RC. Upper gastrointestinal cancer predisposition syndromes. Hematol Oncol Clin North Am 2010;24:815-35. [PMID: 20816576 DOI: 10.1016/j.hoc.2010.06.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
612 Reis CA. Gastric Cancer. Encyclopedia of Cancer 2011. [DOI: 10.1007/978-3-642-16483-5_2329] [Reference Citation Analysis]
613 Axilbund JE, Gross AL, Visvanathan K. Genetics. Early Diagnosis and Treatment of Cancer Series: Breast Cancer 2011. [DOI: 10.1016/b978-1-4160-4932-6.50010-x] [Reference Citation Analysis]
614 Roa JC, Katabi N, Adsay NV. Neoplasms of the Gallbladder. Molecular Pathology Library 2011. [DOI: 10.1007/978-1-4419-7107-4_61] [Reference Citation Analysis]
615 Lee P, Jain S, Pincus MR, Xu R. Molecular Genetic Pathology of Solid Tumors. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00076-2] [Reference Citation Analysis]
616 Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38. [DOI: 10.1007/s00595-010-4370-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
617 Monk IR, Casey PG, Hill C, Gahan CG. Directed evolution and targeted mutagenesis to murinize Listeria monocytogenes internalin A for enhanced infectivity in the murine oral infection model. BMC Microbiol 2010;10:318. [PMID: 21144051 DOI: 10.1186/1471-2180-10-318] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
618 Miura K, Fujibuchi W, Sasaki I. Alternative pre-mRNA splicing in digestive tract malignancy. Cancer Sci. 2011;102:309-316. [PMID: 21134075 DOI: 10.1111/j.1349-7006.2010.01797.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
619 Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG. Pregnancy after prophylactic total gastrectomy. Fam Cancer. 2010;9:331-334. [PMID: 20063069 DOI: 10.1007/s10689-009-9316-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
620 Jézéquel J, Bessaguet C, Verveur C, Faycal J, Richert Z, Metges JP, Volant A, Nousbaum JB, Robaszkiewicz M. Trends in incidence, management, and survival of gastric and cardia carcinomas in the area of Finistere (France) between 1984 and 2003. Eur J Gastroenterol Hepatol 2010;22:1412-9. [PMID: 21389792 DOI: 10.1097/MEG.0b013e3283408865] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
621 Bonifaci N, Górski B, Masojć B, Wokołorczyk D, Jakubowska A, Dębniak T, Berenguer A, Serra Musach J, Brunet J, Dopazo J, Narod SA, Lubiński J, Lázaro C, Cybulski C, Pujana MA. Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS One 2010;5:e14078. [PMID: 21124932 DOI: 10.1371/journal.pone.0014078] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
622 Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631-639. [PMID: 21106365 DOI: 10.1016/j.ejca.2010.10.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
623 Raphael MF, Kluijt I, Koot BG, Smets AM, Tilanus ME, Bras J, van de Wetering MD. Gastric adenocarcinoma in a 13-year-old boy: a diagnosis not often seen in this age group. Pediatr Hematol Oncol 2011;28:71-7. [PMID: 21083354 DOI: 10.3109/08880018.2010.520820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
624 Svrcek M. [Hereditary gastric cancer: the pathologist's point of view]. Ann Pathol 2010;30:84-7. [PMID: 21055555 DOI: 10.1016/j.annpat.2010.08.005] [Reference Citation Analysis]
625 Spangler B, Vardimon L, Bosserhoff AK, Kuphal S. Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res 2011;24:148-64. [PMID: 20977688 DOI: 10.1111/j.1755-148X.2010.00787.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
626 Roukos DH. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J 2011;11:81-92. [PMID: 20975737 DOI: 10.1038/tpj.2010.81] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
627 Becker K, Keller G. Gastric Cancer. eLS 2010. [DOI: 10.1002/9780470015902.a0006056.pub2] [Reference Citation Analysis]
628 Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C;  International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436-444. [PMID: 20591882 DOI: 10.1136/jmg.2009.074237] [Cited by in Crossref: 380] [Cited by in F6Publishing: 411] [Article Influence: 29.2] [Reference Citation Analysis]
629 Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N, Robson ME, Ryan PD, Olopade OI, Domchek SM, Ford J, Isaacs C, Brown P, Balmana J, Razzak AR, Miron P, Coffey K, Terry MB, John EM, Andrulis IL, Knight JA, O'Malley FP, Daly M, Bender P, kConFab, Moore R, Southey MC, Hopper JL, Garber JE, Huntsman DG. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet. 2011;48:64-68. [PMID: 20921021 DOI: 10.1136/jmg.2010.079814] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
630 Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti MA. The role of surgery in cancer prevention. Curr Probl Surg 2010;47:750-830. [PMID: 20816140 DOI: 10.1067/j.cpsurg.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
631 Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2010;2:a002915. [PMID: 20182623 DOI: 10.1101/cshperspect.a002915] [Cited by in Crossref: 424] [Cited by in F6Publishing: 465] [Article Influence: 32.6] [Reference Citation Analysis]
632 Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol 2010; 2(9): 342-347 [PMID: 21160805 DOI: 10.4251/wjgo.v2.i9.342] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
633 Wolf E, Geigl J, Svrcek M, Vieth M, Langner C. Hereditäres Magenkarzinom. Pathologe 2010;31:423-9. [DOI: 10.1007/s00292-010-1353-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
634 Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010;18:33S-36S. [PMID: 20484258 DOI: 10.1177/1066896910366463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
635 Matsukuma KE, Mullins FM, Dietz L, Zehnder JL, Ford JM, Chun NM, Schrijver I. Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. Human Pathology 2010;41:1200-3. [DOI: 10.1016/j.humpath.2010.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
636 Lee AF, Rees H, Owen DA, Huntsman DG. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. Am J Surg Pathol 2010;34:1007-13. [PMID: 20534996 DOI: 10.1097/PAS.0b013e3181e28985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
637 Zhang KJ, Wang DS, Zhang SY, Jiao XL, Li CW, Wang XS, Yu QC, Cui HN. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma. J Exp Clin Cancer Res. 2010;29:88. [PMID: 20594328 DOI: 10.1186/1756-9966-29-88] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
638 Roukos DH. Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 2010;10:247-50. [PMID: 20370580 DOI: 10.1586/erm.10.10] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
639 Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B. Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. J Oncol 2010;2010:530745. [PMID: 20628524 DOI: 10.1155/2010/530745] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
640 Wang DQ, Zhou JN, Song L, Li SP, Ding JH, Li JT, Ma GJ, Chen SQ, Zhang XM. Genotype frequencies of the Val384Asp missense mutation in the hMLH1 gene in patients with familial gastric cancer. Shijie Huaren Xiaohua Zazhi 2010; 18(16): 1669-1675 [DOI: 10.11569/wcjd.v18.i16.1669] [Reference Citation Analysis]
641 Leite M, Corso G, Sousa S, Milanezi F, Afonso LP, Henrique R, Soares JM, Castedo S, Carneiro F, Roviello F. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer. 2011;128:1606-1613. [PMID: 20533283 DOI: 10.1002/ijc.25495] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
642 Ghaffari S, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. European Journal of Surgical Oncology (EJSO) 2010;36:559-62. [DOI: 10.1016/j.ejso.2010.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
643 Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer. 2010;10:353-361. [PMID: 20414203 DOI: 10.1038/nrc2840] [Cited by in Crossref: 160] [Cited by in F6Publishing: 169] [Article Influence: 12.3] [Reference Citation Analysis]
644 Corso G, Pedrazzani C, Marrelli D, Pinto E, Roviello F. Familial gastric cancer and Li-Fraumeni syndrome. European Journal of Cancer Care 2010;19:377-81. [DOI: 10.1111/j.1365-2354.2008.01066.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
645 Ju H, Lim B, Kim M, Kim YS, Kim WH, Ihm C, Noh SM, Han DS, Yu HJ, Choi BY, Kang C. A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression. Neoplasia 2009;11:1340-7. [PMID: 20019842 DOI: 10.1593/neo.91132] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
646 Yoshida T, Ono H, Kuchiba A, Saeki N, Sakamoto H. Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example. Cancer Sci 2010;101:1582-9. [PMID: 20507324 DOI: 10.1111/j.1349-7006.2010.01590.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
647 Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: Translation of CDH1 germline mutations into clinical practice. Gastric Cancer. 2010;13:1-10. [PMID: 20373070 DOI: 10.1007/s10120-009-0531-x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 8.5] [Reference Citation Analysis]
648 Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 2010;20:210-7. [PMID: 20347291 DOI: 10.1016/j.gde.2010.03.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
649 Roger L, Jullien L, Gire V, Roux P. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010;123:1295-1305. [PMID: 20332115 DOI: 10.1242/jcs.061002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
650 Chao C, Hellmich MR. Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes. 2010;17:33-39. [PMID: 19907321 DOI: 10.1097/med.0b013e328333faf8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
651 Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10:353-358. [PMID: 19434079 DOI: 10.1038/nrg 2574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
652 Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10:353-358. [PMID: 19434079 DOI: 10.1038/nrg2574] [Cited by in Crossref: 296] [Cited by in F6Publishing: 320] [Article Influence: 22.8] [Reference Citation Analysis]
653 Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Hoefler H, Thaler J. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Eur J Gastroenterol Hepatol 2010;22:306-10. [PMID: 19474748 DOI: 10.1097/MEG.0b013e32832bab9a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
654 Cullinane AR, Straatman-Iwanowska A, Zaucker A, Wakabayashi Y, Bruce CK, Luo G, Rahman F, Gürakan F, Utine E, Ozkan TB. Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat Genet. 2010;42:303-312. [PMID: 20190753 DOI: 10.1038/ng.538] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 9.8] [Reference Citation Analysis]
655 Wu J, Wang D, Song L, Li S, Ding J, Chen S, Li J, Ma G, Zhang X. A new familial gastric cancer-related gene polymorphism: T1151A in the mismatch repair gene hMLH1. Mol Biol Rep 2011;38:3181-7. [PMID: 20177793 DOI: 10.1007/s11033-010-9989-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
656 Bell DW. Our changing view of the genomic landscape of cancer. J Pathol 2010;220:231-43. [PMID: 19918804 DOI: 10.1002/path.2645] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 4.9] [Reference Citation Analysis]
657 Fei Y, Hu J, Liu S, Liu X, Wang F, Gong J. E-cadherin-160 C/A promoter polymorphism and risk of pancreatic carcinoma in Chinese population. Cancer Genet Cytogenet 2010;197:25-31. [PMID: 20113833 DOI: 10.1016/j.cancergencyto.2009.10.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
658 Ansquer Y, Santulli P, Colas C, Jamali M, Tournigand C, Duperray L, Duperray B, Jannet D, Carbonne B. [Lobular intra-epithelial neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ]. J Gynecol Obstet Biol Reprod (Paris) 2010;39:91-101. [PMID: 20116180 DOI: 10.1016/j.jgyn.2009.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
659 de la Peña S, L. Sampieri C, León-córdoba K. Metaloproteasas de la matriz extracelular como marcadores moleculares en cáncer gástrico. Medicina Clínica 2010;134:123-6. [DOI: 10.1016/j.medcli.2009.09.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
660 Becker K, Luber B. E-cadherin. AfCS-Nature Molecule Pages. [DOI: 10.1038/mp.a003905.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
661 Silva LD, Simpson PT, Lakhani SR. Lobular Carcinoma in Situ. Management of Breast Diseases 2010. [DOI: 10.1007/978-3-540-69743-5_11] [Reference Citation Analysis]
662 Pandalai PK, Yoon SS. Hereditary Diffuse Gastric Cancer. Principles of Clinical Cancer Genetics 2010. [DOI: 10.1007/978-0-387-93846-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
663 Hitchins MP. Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv Genet 2010;70:201-43. [PMID: 20920750 DOI: 10.1016/B978-0-12-380866-0.60008-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
664 A. Abrams J, Wang TC. Adenocarcinoma and Other Tumors of the Stomach. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00054-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
665 Rossi BM, de Oliveira Ferreira F. Extracolonic Tumors. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_17] [Reference Citation Analysis]
666 Sugimachi K, Higashi H, Kitagawa D, Tanaka J, Nagayoshi Y, Mizuta A, Makino I, Aso M, Shimokama T. A Case of Hereditary Gastric Cancer with Diffuse Multiple Lesions in the Stomach. Jpn J Gastroenterol Surg 2010;43:918-922. [DOI: 10.5833/jjgs.43.918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
667 Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, Fukamachi H, Ito Y. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 2010;138:255-65.e1-3. [PMID: 19706291 DOI: 10.1053/j.gastro.2009.08.044] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 5.1] [Reference Citation Analysis]
668 Bellacosa A, Larue L. PI3K/AKT Pathway and the Epithelial-Mesenchymal Transition. Cancer Genome and Tumor Microenvironment 2010. [DOI: 10.1007/978-1-4419-0711-0_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
669 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
670 Itadani H, Oshima H, Oshima M, Kotani H. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009;10:615. [PMID: 20015407 DOI: 10.1186/1471-2164-10-615] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
671 Pinheiro H, Bordeira-Carriço R, Seixas S, Carvalho J, Senz J, Oliveira P, Inácio P, Gusmão L, Rocha J, Huntsman D, Seruca R, Oliveira C. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010;19:943-52. [PMID: 19965908 DOI: 10.1093/hmg/ddp537] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
672 Mukherji D, Benepal T. A review of in vitro and in vivo models of oesophageal and gastric cancer. Expert Opin Drug Discov 2009;4:1267-79. [PMID: 23480466 DOI: 10.1517/17460440903410203] [Reference Citation Analysis]
673 Lockhart ME, Canon CL. Epidemiology of gastric cancer. Gastric Cancer 2009. [DOI: 10.1017/cbo9780511691751.003] [Reference Citation Analysis]
674 Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer. 2010;102:237-242. [PMID: 19888225 DOI: 10.1038/sj.bjc.6605380] [Cited by in Crossref: 116] [Cited by in F6Publishing: 133] [Article Influence: 8.3] [Reference Citation Analysis]
675 Shan YF, Shen X, Xie YK, Chen JC, Shi HQ, Yu ZP, Song QT, Zhou MT, Zhang QY. Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells. Acta Pharmacol Sin 2009;30:1537-42. [PMID: 19820721 DOI: 10.1038/aps.2009.139] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
676 Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1:a003129. [PMID: 20457567 DOI: 10.1101/cshperspect.a003129] [Cited by in Crossref: 420] [Cited by in F6Publishing: 471] [Article Influence: 30.0] [Reference Citation Analysis]
677 Hollestelle A, Elstrodt F, Timmermans M, Sieuwerts AM, Klijn JGM, Foekens JA, den Bakker MA, Schutte M. Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations. Breast Cancer Res Treat 2010;122:125-33. [DOI: 10.1007/s10549-009-0545-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
678 Akaboshi S, Watanabe S, Hino Y, Sekita Y, Xi Y, Araki K, Yamamura K, Oshima M, Ito T, Baba H. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer. Am J Pathol. 2009;175:1675-1685. [PMID: 19729480 DOI: 10.2353/ajpath.2009.090069] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
679 Hishida A, Matsuo K, Goto Y, Mitsuda Y, Naito M, Wakai K, Tajima K, Hamajima N. Significant association of RUNX3 T/A polymorphism at intron 3 (rs760805) with the risk of gastric atrophy in Helicobacter pylori seropositive Japanese. J Gastroenterol 2009;44:1165-71. [PMID: 19728008 DOI: 10.1007/s00535-009-0118-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
680 Jia H, Jiang X, Zhao Z, Ge Y, Lu J, Zhao Y, Cui B, Ning G. High frequency of down-regulation of E-cadherin detected in benign sporadic insulinomas by multiplex ligation-dependent probe amplification. Human Pathology 2009;40:1336-41. [DOI: 10.1016/j.humpath.2009.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
681 Pittman AM, Twiss P, Broderick P, Lubbe S, Chandler I, Penegar S, Houlston RS. The CDH1-160C>A polymorphism is a risk factor for colorectal cancer. Int J Cancer. 2009;125:1622-1625. [PMID: 19569232 DOI: 10.1002/ijc.24542] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
682 Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28:151-166. [PMID: 19153669 DOI: 10.1007/s10555-008-9179-y] [Cited by in Crossref: 564] [Cited by in F6Publishing: 607] [Article Influence: 40.3] [Reference Citation Analysis]
683 Yamada H, Shinmura K, Goto M, Iwaizumi M, Konno H, Kataoka H, Yamada M, Ozawa T, Tsuneyoshi T, Tanioka F, Sugimura H. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol Cancer 2009;8:63. [PMID: 19671196 DOI: 10.1186/1476-4598-8-63] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
684 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
685 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 11.1] [Reference Citation Analysis]
686 Ziogas D, Roukos DH. CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 2009;16:2678-81. [PMID: 19636637 DOI: 10.1245/s10434-009-0598-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 5.2] [Reference Citation Analysis]
687 Berx G, Nollet F, Roy FV. Dysregulation of the E-Cadherin/Catenin Complex by Irreversible Mutations in Human Carcinomas. Cell Adhesion and Communication 2009;6:171-84. [DOI: 10.3109/15419069809004474] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 5.3] [Reference Citation Analysis]
688 Deplazes J, Fuchs M, Rauser S, Genth H, Lengyel E, Busch R, Luber B. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation. Hum Mol Genet 2009;18:3632-44. [PMID: 19584084 DOI: 10.1093/hmg/ddp312] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
689 Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
690 McRonald FE, Morris MR, Gentle D, Winchester L, Baban D, Ragoussis J, Clarke NW, Brown MD, Kishida T, Yao M, Latif F, Maher ER. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol Cancer 2009;8:31. [PMID: 19493342 DOI: 10.1186/1476-4598-8-31] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
691 Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48. [PMID: 19269290 DOI: 10.1053/j.gastro.2009.02.065] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
692 Roukos DH. Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 2009;9:1-6. [PMID: 19099341 DOI: 10.1586/14737159.9.1.1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 5.1] [Reference Citation Analysis]
693 Hebbard PC, Macmillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol. 2009;16:1890-1895. [PMID: 19408054 DOI: 10.1245/s10434-009-0471-z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
694 De Grève J, Sermijn E, De Brakeleer S, Ren Z, Teugels E. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol 2008;20:605-13. [PMID: 18841041 DOI: 10.1097/CCO.0b013e3283139173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
695 Nam KT, Lee HJ, Mok H, Romero-Gallo J, Crowe JE Jr, Peek RM Jr, Goldenring JR. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology 2009;136:1288-96. [PMID: 19230855 DOI: 10.1053/j.gastro.2008.12.037] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
696 Balcer-kubiczek EK, Garofalo MC. Molecular Targets in Gastric Cancer and Apoptosis. Apoptosis in Carcinogenesis and Chemotherapy. [DOI: 10.1007/978-1-4020-9597-9_7] [Reference Citation Analysis]
697 Corso G, Berardi A, Marrelli D, Pedrazzani C, Garosi L, Pinto E, Roviello F. CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev. 2009;18:46-49. [PMID: 19077564 DOI: 10.1097/CEJ.0b013e32830c8d70] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
698 Li X, Zhang Y, Cao S, Chen X, Lu Y, Jin H, Sun S, Chen B, Liu J, Ding J, Wu K, Fan D. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis. Int J Cancer 2009;124:713-21. [DOI: 10.1002/ijc.23967] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
699 Roukos DH. Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 2009;16:795-8. [PMID: 19169753 DOI: 10.1245/s10434-009-0317-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
700 Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet. 2009;18:1545-1555. [PMID: 19168852 DOI: 10.1093/hmg/ddp046] [Cited by in Crossref: 146] [Cited by in F6Publishing: 157] [Article Influence: 10.4] [Reference Citation Analysis]
701 Elston MS, Gill AJ, Conaglen JV, Clarkson A, Cook RJ, Little NS, Robinson BG, Clifton-Bligh RJ, McDonald KL. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. J Clin Endocrinol Metab 2009;94:1436-42. [PMID: 19158195 DOI: 10.1210/jc.2008-2075] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
702 Pedrazzani C, Corso G, Velho S, Leite M, Pascale V, Bettarini F, Marrelli D, Seruca R, Roviello F. Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer. 2009;8:215-220. [PMID: 19152022 DOI: 10.1007/s10689-008-9231-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
703 Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. 2008;27:6920-6929. [PMID: 19029934 DOI: 10.1038/onc.2008.343] [Cited by in Crossref: 561] [Cited by in F6Publishing: 595] [Article Influence: 40.1] [Reference Citation Analysis]
704 Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene. 2008;27:6920-6929. [PMID: 19029934 DOI: 10.1038/onc.2008.343.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
705 Hatakeyama M. Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene. 2008;27:7047-7054. [PMID: 19029944 DOI: 10.1038/onc.2008.353] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
706 Volk J, Parsonnet J. Epidemiology of Gastric Cancer and Helicobacter pylori. The Biology of Gastric Cancers 2009. [DOI: 10.1007/978-0-387-69182-4_2] [Reference Citation Analysis]
707 Gomperts BD, Kramer IM, Tatham PE. Adhesion Molecules in the Regulation of Cell Differentiation: Mainly About Wnt. Signal Transduction 2009. [DOI: 10.1016/b978-0-12-369441-6.00014-3] [Reference Citation Analysis]
708 Sepulveda AR, Aisner DL. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2009. [DOI: 10.1016/b978-0-12-374419-7.00019-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
709 Correa P, Camargo MC, Piazuelo MB. Overview and Pathology of Gastric Cancer. The Biology of Gastric Cancers 2009. [DOI: 10.1007/978-0-387-69182-4_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
710 Lauwers GY. Epithelial Neoplasms of the Stomach. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 563-79. [DOI: 10.1016/b978-141604059-0.50024-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
711 Galysh R, Powell SM. Cancer Genetics of Human Gastric Adenocarcinoma. The Biology of Gastric Cancers 2009. [DOI: 10.1007/978-0-387-69182-4_10] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
712 Mukherjee A, Mcgarrity T, Staveley-o'carroll K, Ruggiero F, Baker MJ. Hereditary diffuse gastric cancer: lifesaving potential of prophylactic gastrectomy. Community Oncology 2009;6:41-5. [DOI: 10.1016/s1548-5315(11)70377-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
713 Chan AOO, Wong BC. Deregulation of E-Cadherin in Precancerous Lesions and Gastric Cancer. The Biology of Gastric Cancers 2009. [DOI: 10.1007/978-0-387-69182-4_14] [Reference Citation Analysis]
714 Nathanson KL. Other Hereditary Breast Cancer Syndromes and Genes. The Role of Genetics in Breast and Reproductive Cancers 2009. [DOI: 10.1007/978-1-4419-0477-5_7] [Reference Citation Analysis]
715 Coleman WB, Rubinas TC. Neoplasia. Molecular Pathology 2009. [DOI: 10.1016/b978-0-12-374419-7.00004-4] [Reference Citation Analysis]
716 Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
717 Bezdekova M, Brychtova S, Sedlakova E, Steigerova J, Hlobilkova A, Bienova M, Kucerova R, Brychta T, Krejci V, Kolar Z. Immunohistochemical assessment of E-cadherin and beta-catenin in trichofolliculomas and trichoepitheliomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:251-5. [PMID: 18345259 DOI: 10.5507/bp.2007.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
718 Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216:295-306. [PMID: 18788075 DOI: 10.1002/path.2426] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 6.6] [Reference Citation Analysis]
719 Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, Caldas C, Fitzgerald RC. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol. 2008;216:286-294. [PMID: 18825658 DOI: 10.1002/path.2415] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 6.0] [Reference Citation Analysis]
720 Koea JB. Indigenous trauma: A New Zealand perspective. Injury 2008;39:S11-8. [DOI: 10.1016/s0020-1383(08)70024-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
721 Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M. DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics 2008;9:1917-28. [DOI: 10.2217/14622416.9.12.1917] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
722 Bajpai S, Correia J, Feng Y, Figueiredo J, Sun SX, Longmore GD, Suriano G, Wirtz D. {alpha}-Catenin mediates initial E-cadherin-dependent cell-cell recognition and subsequent bond strengthening. Proc Natl Acad Sci U S A 2008;105:18331-6. [PMID: 19017792 DOI: 10.1073/pnas.0806783105] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
723 Leckband D. From Single Molecules to Living Cells: Nanomechanical Measurements of Cell Adhesion. Cel Mol Bioeng 2008;1:312-26. [DOI: 10.1007/s12195-008-0029-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
724 Houlston RS, Webb E, Broderick P, Pittman AM, Di Bernardo MC, Lubbe S, Chandler I, Vijayakrishnan J, Sullivan K, Penegar S, Carvajal-Carmona L, Howarth K, Jaeger E, Spain SL, Walther A, Barclay E, Martin L, Gorman M, Domingo E, Teixeira AS, Kerr D, Cazier JB, Niittymäki I, Tuupanen S, Karhu A, Aaltonen LA, Tomlinson IP, Farrington SM, Tenesa A, Prendergast JG, Barnetson RA, Cetnarskyj R, Porteous ME, Pharoah PD, Koessler T, Hampe J, Buch S, Schafmayer C, Tepel J, Schreiber S, Völzke H, Chang-Claude J, Hoffmeister M, Brenner H, Zanke BW, Montpetit A, Hudson TJ, Gallinger S, Campbell H, Dunlop MG; COGENT Study., Colorectal Cancer Association Study Consortium., CoRGI Consortium. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008;40:1426-35. [PMID: 19011631 DOI: 10.1038/ng.262] [Cited by in Crossref: 428] [Cited by in F6Publishing: 462] [Article Influence: 28.5] [Reference Citation Analysis]
725 Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer. 2008;113:1850-1856. [PMID: 18798546 DOI: 10.1002/cncr.23650] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
726 Boland CR. The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy. Gastrointest Endosc Clin N Am 2008;18:401-13, vii. [PMID: 18674693 DOI: 10.1016/j.giec.2008.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
727 Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma. Gastric Cancer 2008;11:149-59. [PMID: 18825309 DOI: 10.1007/s10120-008-0468-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
728 Lynch HT, Silva E, Wirtzfeld D, Hebbard P, Lynch J, Huntsman DG. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin North Am 2008;88:759-78, vi-vii. [PMID: 18672140 DOI: 10.1016/j.suc.2008.04.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
729 Wakatsuki K, Yamada Y, Narikiyo M, Ueno M, Takayama T, Tamaki H, Miki K, Matsumoto S, Enomoto K, Yokotani T. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol. 2008;98:124-129. [PMID: 18521835 DOI: 10.1002/jso.21093] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
730 Oseni T, Jatoi I. An Overview of the Role of Prophylactic Surgery in the Management of Individuals with a Hereditary Cancer Predisposition. Surgical Clinics of North America 2008;88:739-58. [DOI: 10.1016/j.suc.2008.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
731 Cisco RM, Norton JA. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions. Future Oncology 2008;4:553-9. [DOI: 10.2217/14796694.4.4.553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
732 Caron O, Schielke A, Svrcek M, Fléjou JF, Garzon J, Olschwang S, Sézeur A. Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family. Am J Gastroenterol 2008;103:2160-1. [PMID: 18796125 DOI: 10.1111/j.1572-0241.2008.01982_17.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
733 Wiech T, Nikolopoulos E, Weis R, Langer R, Bartholomé K, Timmer J, Walch AK, Höfler H, Werner M. Genome-wide analysis of genetic alterations in Barrett's adenocarcinoma using single nucleotide polymorphism arrays. Lab Invest 2009;89:385-97. [DOI: 10.1038/labinvest.2008.67] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
734 Smith JJ, Deane NG, Dhawan P, Beauchamp RD. Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology. Surgery 2008;144:353-66. [PMID: 18707034 DOI: 10.1016/j.surg.2008.05.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
735 Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818-829. [PMID: 18539112 DOI: 10.1016/j.devcel.2008.05.009] [Cited by in Crossref: 2157] [Cited by in F6Publishing: 2311] [Article Influence: 143.8] [Reference Citation Analysis]
736 Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, Burke W, Lynch HT, Garber JE, Huntsman DG. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008;7:73-82. [PMID: 18046629 DOI: 10.1007/s10689-007-9172-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
737 Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): Pathologic findings with clinical implications. Am J Surg Pathol. 2008;32:799-809. [PMID: 18391748 DOI: 10.1097/pas.0b013e31815e7f1a] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 7.3] [Reference Citation Analysis]
738 Lynch HT, Kaurah P, Wirtzfeld D, Rubinstein WS, Weissman S, Lynch JF, Grady W, Wiyrick S, Senz J, Huntsman DG. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer. 2008;112:2655-2663. [PMID: 18442100 DOI: 10.1002/cncr.23501] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
739 Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118:1727-38. [PMID: 18431520 DOI: 10.1172/JCI34944] [Cited by in Crossref: 39] [Cited by in F6Publishing: 154] [Article Influence: 2.6] [Reference Citation Analysis]
740 Field K, Michael M, Leong T. Locally advanced and metastatic gastric cancer: current management and new treatment developments. Drugs 2008;68:299-317. [PMID: 18257608 DOI: 10.2165/00003495-200868030-00004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
741 Natalwala A, Spychal R, Tselepis C. Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol 2008; 14(24): 3792-3797 [PMID: 18609701 DOI: 10.3748/wjg.14.3792] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 90] [Article Influence: 5.1] [Reference Citation Analysis]
742 Khushalani N. Cancer of the esophagus and stomach. Mayo Clin Proc. 2008;83:712-722. [PMID: 18533089 DOI: 10.4065/83.6.712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
743 Kovacic JC, Boehm M. Resident vascular progenitor cells: an emerging role for non-terminally differentiated vessel-resident cells in vascular biology. Stem Cell Res 2009;2:2-15. [PMID: 19383404 DOI: 10.1016/j.scr.2008.05.005] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
744 Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol. 2008;30:315-327. [PMID: 18521607 DOI: 10.1007/s00281-008-0124-5] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
745 Khushalani NI. Cancer of the Esophagus and Stomach. Mayo Clinic Proceedings 2008;83:712-22. [DOI: 10.1016/s0025-6196(11)60900-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
746 Dachs GU, Currie MJ, McKenzie F, Jeffreys M, Cox B, Foliaki S, Le Marchand L, Robinson BA. Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncol 2008;9:473-84. [PMID: 18452858 DOI: 10.1016/S1470-2045(08)70127-X] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
747 Nasri S, More H, Graziano F, Ruzzo A, Wilson E, Dunbier A, McKinney C, Merriman T, Guilford P, Magnani M. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population. BMC Cancer. 2008;8:138. [PMID: 18482459 DOI: 10.1186/1471-2407-8-138] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
748 Fujii S, Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci. 2008;99:738-746. [PMID: 18377425 DOI: 10.1111/j.1349-7006.2008.00743.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 7.3] [Reference Citation Analysis]
749 Ziogas D, Baltogiannis G, Fatouros M, Roukos DH. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 2008;247:714-5; author reply 715-6. [PMID: 18362641 DOI: 10.1097/SLA.0b013e31816a5072] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
750 Humar B, Guilford P. Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer. Future Oncol. 2008;4:229-239. [PMID: 18407736 DOI: 10.2217/14796694.4.2.229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
751 Karam R, Carvalho J, Bruno I, Graziadio C, Senz J, Huntsman D, Carneiro F, Seruca R, Wilkinson MF, Oliveira C. The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene. 2008;27:4255-4260. [PMID: 18427545 DOI: 10.1038/onc.2008.62] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
752 Yu JS, Koujak S, Nagase S, Li CM, Su T, Wang X, Keniry M, Memeo L, Rojtman A, Mansukhani M, Hibshoosh H, Tycko B, Parsons R. PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 2008;27:4657-65. [PMID: 18408767 DOI: 10.1038/onc.2008.101] [Cited by in Crossref: 106] [Cited by in F6Publishing: 117] [Article Influence: 7.1] [Reference Citation Analysis]
753 Engelmark MT, Ivansson EL, Magnusson JJ, Gustavsson IM, Wyöni P, Ingman M, Magnusson PKE, Gyllensten UB. Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis. Hum Genet 2008;123:437-43. [DOI: 10.1007/s00439-008-0494-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
754 Tischoff I, Tannapfel A. DNA methylation in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1741-1748 [PMID: 18350605 DOI: 10.3748/wjg.14.1741] [Cited by in CrossRef: 125] [Cited by in F6Publishing: 134] [Article Influence: 8.3] [Reference Citation Analysis]
755 Leung WK, Wu M, Kakugawa Y, Kim JJ, Yeoh K, Goh KL, Wu K, Wu D, Sollano J, Kachintorn U, Gotoda T, Lin J, You W, Ng EK, Sung JJ. Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 2008;9:279-87. [DOI: 10.1016/s1470-2045(08)70072-x] [Cited by in Crossref: 578] [Cited by in F6Publishing: 642] [Article Influence: 38.5] [Reference Citation Analysis]
756 Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku WY, Groshen S, Jones LW, Imam SA. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone. Prostate 2008;68:78-84. [PMID: 18008331 DOI: 10.1002/pros.20670] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
757 Qian X, Huang C, Cho CH, Hui WM, Rashid A, Chan AO. E-cadherin promoter hypermethylation induced by interleukin-1beta treatment or H. pylori infection in human gastric cancer cell lines. Cancer Lett. 2008;263:107-113. [PMID: 18249489 DOI: 10.1016/j.canlet.2007.12.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
758 Robertson EV, Jankowski JA. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol 2008;103:443-9. [PMID: 17925001 DOI: 10.1111/j.1572-0241.2007.01574.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5]